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CHAPTER I 
INTRODUCTION 
1.1 CENTRAL DOGMA 
 The survival of a cell depends on its ability to regulate its genetic program, which 
is crucial for growth, proliferation and homeostasis. Understanding how these programs 
operate and are regulated is the focus of a wide range of biological disciplines including 
evolution, genetics, biochemistry and developmental biology. The central dogma of 
molecular biology describes the process of gene expression. The first step in gene 
expression is the conversion of genetic programs coded in the bases of DNA to RNA by 
a process called transcription. In the next step, RNA is translated into proteins, which 
perform nearly all the vital functions of a cell. The basic unit of the genetic program is a 
‘gene’, which is a region of the DNA that includes the promoter, the coding region and 
the terminator. Although, gene expression is regulated at multiple levels, transcription is 
the first major step, and a primary target of regulatory processes. In order to have an 
insight into the regulation of gene expression, therefore, it is critical to understand how 
transcription is regulated. 
1.2 RNA POLYMERASES 
 In eukaryotes, the process of transcription is performed by at least three different 
RNA polymerases (RNAP) (253, 254). RNAP I and III transcribe ribosomal rRNA, tRNA, 
and small nuclear RNAs (snRNA), while RNAP II is the enzyme that transcribes protein 
coding genes as well as some snRNAs and non-coding RNAs (300). The overall 
process of transcription can be broken down into three basic steps: initiation, elongation 
and termination. Transcription often begins in response to a signal, which is transduced 
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to a protein inside the cell called the ‘activator’. This triggers the activator-dependent 
recruitment of the general transcriptional machinery onto the 5' end of a gene called the 
‘promoter’ to form a preinitiation complex (PIC). The initiation of transcription takes 
place while polymerase is still bound to the promoter as a part of the initiation complex. 
Soon after initiation, polymerase is released from the initiation complex leaving behind 
most of the components of initiation complex on the promoter as a ‘scaffold’ (324). This 
transition from initiation to elongation is called promoter clearance, which is 
accompanied by the recruitment of elongation factors. As RNA polymerase reaches the 
3' end of the gene, the termination factors are recruited by the elongating polymerase. 
The termination factors facilitate 3' end processing of mRNA and the release of 
polymerase from the DNA template (266). A schematic of the basic steps in the 
transcription cycle for a protein coding gene is shown in figure 1. 
 All three forms of RNA polymerases exhibit similarity in structure and function 
over a wide range of taxa (174, 175). Eukaryotic RNAP II is comprised of 12 subunits 
(312). These subunits have been named Rpb1 to Rpb12. Of these 12 subunits, only 
Rpb4 and Rpb9 are not essential for survival of yeast cells (311, 313). Ten subunits 
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form the core enzyme, while Rpb4 and Rpb7 form a heterodimer that associates with 
the core to form the 12 subunit structure (39). The core enzyme can perform RNA 
synthesis, but is incapable of initiating transcription from a promoter, and often displays 
termination defect (256).  Rpb4 and Rpb7 were found important for promoter-based 
initiation in vitro, while Rpb4 has also been implicated in the recruitment of 3’ end 
processing/termination factors (11, 68, 161, 256). The subunits Rpb5, Rpb6, Rpb8, 
Rpb10 and Rpb12 are shared by all three RNA polymerases (291). With the exception 
of Rpb1, the remaining subunits also exhibit some degree of similarity among the three 
types of polymerases (116). Years of work from the Roger Kornberg and Patrick Cramer 
laboratories have provided key structural analysis of RNAP II in a complex with other 
transcription factors and DNA (11, 12, 38-40, 51, 69, 104, 148, 153, 154, 162, 195, 304, 
305). These structural studies have provided key insight into the functional aspects of 
the transcription machinery. The two largest subunits of RNAP II together form the 
active site of the enzyme, and the binding sites for DNA and RNA. Rpb3, Rpb6 and 
Rpb11 are important for stabilization of the structure of the complex, while the remaining 
subunits are thought to provide interaction surfaces for regulatory factors (301). The 
largest subunit of RNAP II, Rpb1, contains a unique carboxyl terminal domain (CTD) 
consisting of an array of heptapeptide repeats that serve as a loading dock for the 
transcription factors and RNA processing factors during the transcription cycle (35). 
 The promoter and terminator regions mark the distal ends of a gene and are 
composed of specific sequence elements that bind transcription factors. Upstream 
activating or repressing sequences (UASs or URSs) are located upstream of the core 
promoter and bind activator and repressor proteins respectively. In yeast, the vast 
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majority of UASs and URSs are located upstream of the core promoter element, usually 
within a few hundred bp of the transcription start site (TSS, Fig. 2) (59, 60, 87, 91, 107, 
214, 273, 319). The combinatorial input from these upstream sequences converge onto 
the promoter near the TSS through the action of coactivators and the general 
transcription factors (GTFs). A core promoter was first discovered in humans (Fig. 2), 
which is the minimal set of sequences required to initiate transcription (271). It is a 
sequence of 80 bp centered around the TSS that contains several conserved elements: 
TATA-box, initiator element (INR), TFIIB recognition element (BRE), 
downstream positioning element (DPE) and the motif ten element (MTE). The TATA-
box, INR, DPE and MTE are all sequences recognized by the general transcription 
factor IID (TFIID), while the BRE is an element recognized by the general transcription 
factor IIB (TFIIB) (146). In yeast, only the TATA box and INR like motifs have been 
found, the others are presumably present but too degenerate to be identified positively 
(116). 
1.3 INITIATION 
 The initiation is the most well understood step of transcription owing to a large 
body of in vitro studies being performed using a promoter-containing DNA template and 
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the transcription competent cellular or nuclear extract. Purified fractions of cell or 
nuclear lysate were combined in order to find the various protein factors that could 
perform transcription on these templates. Through further purification of these fractions, 
a minimal set of transcription factors called the ‘general transcription factors’ (GTF) was 
identified which could support initiation of transcription from a generic promoter on a 
naked DNA template (259). These are TBP (TATA-binding protein), TFIIA, TFIIB, TFIIF, 
TFIIE and TFIIH (299). Inside the cell, however, the DNA is organized into a chromatin 
structure, which necessitates the requirement of a number of additional factors to 
overcome the nucleosomal barrier. 
 Initiation of transcription begins with the activator-dependent formation of the PIC 
on the promoter (Fig. 3). The PIC is formed by the ordered recruitment of the GTFs and 
Mediator complex (201). The chromatin remodelers and histone modifiers allow access 
of GTFs and RNA polymerase II to the promoter sequence to form PIC. Activator-
mediated recruitment of general transcription factors on the promoter is facilitated by 
Mediator complex. The general transcription factors are recruited in the following order: 
SAGA/TFIID, TFIIA, TFIIB, TFIIF along with RNAP II, TFIIE and then TFIIH (36). The 
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first factor to be recruited onto the core promoter is either TFIID or SAGA complex. In 
general, TATA-less promoters recruit TFIID, and TATA-containing promoters are 
dependent on SAGA complex for PIC formation (21, 24, 178, 184, 298). TFIID is 
complex composed of TBP (TATA-binding protein) and 14 TBP-associated factors 
(TAFs) (108). In yeast, SAGA was originally discovered for its histone H3 
acetyltransferase activity (106). It is composed of 6 essential subunits and another 15 
non-essential subunits. Five of the six essential subunits, TAF5, TAF6, TAF9, TAF10 
and TAF12, are common with TFIID (24, 275, 315). In yeast, TBP binds to the promoter 
region at approximately 40-120 bp upstream of the TSS, and creates a bend in the DNA 
(Fig. 4) (118). Contrary to the general perception, roughly half of the genes in yeast 
contain 
TATA-less promoters (18). Current genomewide studies have revealed two 
mechanisms involved in transcription activation based on the recruitment of either 
SAGA or TFIID to the core promoter (138, 170, 181, 184, 185). The two mechanisms 
also differ in their requirement for the GTFs necessary to recruit TBP. Promoters 
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utilizing TFIID do not depend on Mediator or TFIIB for the recruitment of TBP to the 
promoter region, while SAGA-dependent promoters require them to recruit TBP (24-26, 
185). TFIIA is a two subunit protein which binds next and stabilizes the TFIID interaction 
with the promoter. TFIIA has also been reported to inhibit repressor interaction with 
TFIID, thereby promoting transcription activation (213, 218). TFIIB is a single subunit 
factor that interacts with TFIID and short regions of DNA flanking the TATA box called 
the TFIIB recognition elements (BRE), which function to help position the polymerase at 
the correct start site (115, 285). TFIIF is a three subunit factor which is recruited to the 
promoter along with RNAP II, and stabilizes its interactions with TFIID and TFIIB (115, 
129, 285). Some studies have also implicated TFIIF function in elongation step of 
transcription (285). TFIIE is a two subunit factor, which facilitates the recruitment of 
TFIIH to the promoter (36). TFIIH is an 11 subunit complex that functions to unwind the 
downstream DNA and phosphorylates the CTD of RNAP II (182).  
One of the factors that has been found vital for transcription on a wide variety of 
promoters is Mediator complex. Mediator has been found to play a critical role in both 
activation and repression of transcription (30). Mediator is composed of 25 subunits and 
has been found to interact with various gene specific activators (27, 30, 31). It acts as a 
bridge between activators and the general transcription machinery (27). Mediator is 
therefore often described as a ‘coactivator’ that bridges the link between activator and 
the GTFs. Recent studies, however, have found Mediator crosslinking to almost every 
RNAP II-transcribed promoter, thereby giving rise to the speculation that Mediator is 
indeed a general transcription factor that gets dissociated form the core promoter 
immediately after initiation of transcription (308). Mediator complex is divided into 4 
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modules: the head, the middle, the tail and the kinase module. The head and kinase 
modules interact extensively with RNAP II, TFIID and TFIIH (88, 176, 180). The kinase 
module has been shown to inhibit transcription by different methods. First, the Srb10 
subunit of the kinase module phosphorylates the CTD of RNAP II before the initiation of 
transcription causing a premature release of RNAP II from the PIC (127). Second, 
Srb10 phosphorylates TFIIH subunit Ccl1 that is a part of TFIIH-kinase submodule 
ultimately resulting in inhibition of kin28 CTD-kinase activity (4). Third, it sterically 
interferes with the recruitment of RNAP II to the PIC by making the head module 
inaccessible to interact with the polymerase (84, 287). The tail module has been shown 
to interact with activators and repressors and regulates recruitment of the transcription 
machinery (226). Each of the three subunits in the tail module, when fused to DNA 
binding domains, were able to activate transcription even in the absence of an activator 
(322). Recent evidence indicates that Mediator is the first transcription factor to respond 
to a signal from the activator and is instrumental in initiating the assembly of the PIC at 
least on a subset of promoters (308). 
 Structural studies and biochemical analysis of the PIC have given an insight into 
the mechanism of transcription by RNAP II. Following assembly of PIC, unwinding of 
about 10 bp surrounding the TSS results in formation of the ‘transcription bubble’ (116). 
With the unwinding of DNA, the PIC makes a transition from ‘closed’ to the ‘open’ 
conformation. The interaction of polymerase subunits with TFIIIF and TFIIB stabilizes 
the bubble. TFIIB contains a domain called the B-finger that inserts into the RNA exit 
channel of RNAP II (Fig. 7) (200). The B-finger contacts the active site in the enzyme 
and helps to correctly position RNAP II at the TSS (Fig. 7). After the synthesis of first 5-
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7 nucleotides, the growing RNA chain begins competing for space with the B-finger in 
RNA exit channel and pushes the B-finger out, thereby dissociating TFIIB from the 
polymerase (162, 195, 257). Ssl2 subunit of TFIIH now contacts the DNA at about 30 bp 
downstream of the TATA-box and unwinds the DNA by a wrench like action (157). Ssl2 
helicase activity then extends the bubble downstream. The forward movement of RNAP 
II on the template coincides with the collapse of the initiation bubble (238). 
Simultaneously, the Kin28 kinase activity of TFIIH phosphorylates RNAP II carboxy-
terminal domain (CTD) at serine-5 (196). The phosphorylation severs the connection of 
polymerase with Mediator, resulting in the release of the complex from the core 
promoter (272). This step called ‘promoter escape’ or ‘promoter clearance’ marks the 
transition of RNAP II into productive elongation. Following initiation of transcription, a 
subset of factors consisting of SAGA/TFIID, TFIIA, TFIIE and TFIIH is left behind on the 
promoter forming a ‘scaffold’ that facilitates reinitiation of subsequent rounds of 
transcription (325). 
1.4 ELONGATION  
 Transcription elongation begins immediately after promoter clearance, and in 
most eukaryotes is accompanied by DSIF (DRB-sensitive inducing factor)-mediated 
pausing of RNAP II just downstream of the promoter element (320). Such promoter 
proximal pausing of polymerase, however, has not been observed in budding yeast. 
The elongation of transcripts on a naked DNA template under in vitro conditions 
requires only TFIIF and TFIIS (140). The elongation in yeast is stimulated by the 
Ctk1/Bur1, which phosphorylates the CTD of RNAP II at serine-2, and facilitates 
recruitment of RNA processing factors (309). A similar role of serine-2 phosphorylation 
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has been demonstrated in higher eukaryotes (81). Apart from Mediator, TFIIF is the only 
GTF that also plays a role in elongation of transcription by RNAP II (120, 219, 261, 
290). The AT-rich sequences in the body of a gene present a barrier to elongation as 
RNAP II frequently backtracks on such sequences leading to the misalignment of 
growing 3' end of RNA with the active site. TFIIS, a factor that possesses 3’ to 5’ 
exoribonuclease activity, promotes the release of backtracked RNAP II by realigning the 
active site with the 3' end of mRNA (168, 307). Under in vivo conditions, elongating 
polymerase has to overcome the nucleosomal barrier. There are three types of factors 
that help polymerase move through the chromatin template. These are histone 
chaperone, ATP-dependent remodeling factors and histone modifying enzymes. FACT 
and Spt6 are histone chaperones for H2A-H2B and H3-H4 respectively (32, 237). They 
are essential for smooth passage of polymerase through the chromatin template during 
elongation (9, 121, 149). The ATP-dependent chromatin remodelers like RSC and SWI-
SNF complexes have also been shown to overcome nucleosomal barrier in yeast (42, 
132). The histone modifying enzymes that are crucial for elongation step are COMPASS 
(Complex of Proteins Associated with Set1) and HAT complexes like NuA4 complex 
(75, 76, 215). As RNAP II progresses through the body of a gene, the COMPASS 
functions to methylate histones at H3K4 near the promoter, which helps recruit other 
histone modifying enzymes that acetylate histones in front of the progressing RNAP II. 
In turn, this allows for the ATP-dependent chromatin remodeling complexes RSC and 
Chd1 along with the histone chaperone FACT to function and allow passage of RNAP II 
around the nucleosomal barriers during elongation (183). 
1.5 TERMINATION 
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 Termination is one of the least understood steps of eukaryotic transcription cycle. 
Recent studies, however, have begun to shed light on the mechanism of termination of 
transcription by RNAP II. Termination requires both cis-acting elements and the trans-
acting termination factors (73, 112, 205, 327). The termination by RNAP II involves 
cleavage and polyadenylation of the precursor mRNA, followed by the release of RNAP 
II from the template (29). Termination serves a variety of critical functions in the cell. 
First, it allows recycling of RNAP II to drive subsequent rounds of transcription. Second, 
the addition of a poly(A) tail provides protection to mRNA from 3’ exonucleolytic 
cleavage (303). In addition, polyadenylation also improves the translatability of mRNA 
(206). Third, termination ensures that RNAP II doesn’t progress further downstream 
wasting cellular energy and possibly interfering with the transcription of neighboring 
genes (100, 255). Last, proper termination also results in the recruitment of RNA export 
factors, which bind the polyadenylated RNA and export it to the cytoplasm for 
translation (206). 
 Termination is coupled to 3' end processing of precursor mRNA. The same set of 
factors is required for both the cleavage and polyadenylation of mRNA as well as 
dissociation of polymerase from the template (167). In yeast, the termination factors are 
organized into three complexes with a combined size of over a megadalton (Fig. 5.) 
(216). These are cleavage factor I (CF1) complex, cleavage and polyadenylation factor 
(CPF) complex, and the Rat1 complex. The CF1 complex is composed of 5 subunits: 
Rna15, Rna14, Pcf11, Hrp1, and Clp1 (109, 152). The CPF complex is composed of 15 
subunits: Fip1, Yth1, Pfs2, Pta1, Yhh1, Ydh1, Ysh1, Pap1, Pti1, Ssu72, Glc7, Syc1, 
Swd2, Cft1, and Mpe1 (28, 150). The Rat1 complex is composed of 3 subunits: Rat1, 
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Rtt103, and Rai1 (198). The names of the CF1 and CPF complexes may be misleading 
based on in vitro studies that have shown a requirement for the entire CF1 complex and 
the majority of CPF subunits for cleavage and polyadenylation to occur. The Rat1 
complex requires the exoribonuclease activity of the Rat1 protein in order to function in 
termination (198). Interestingly, export of the polyadenylated mRNA into the cytoplasm 
is compromised in mutants of the Rat1 complex (8). 
 There are two prevailing models explaining the mechanism of termination by 
RNAP II: (1) allosteric model, and (2) torpedo model. According to the allosteric model, 
there is a change in conformation of the transcription complex as RNAP II transcribes 
over the terminator (241). This change causes the release of elongation factors and the 
recruitment of termination factors which then bring about termination of transcription. 
According to torpedo model, termination is facilitated by the Rat1 exonucleolytic 
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complex, which begins degrading the cleaved RNA that is still attached to the 
transcribing polymerase at the 3' end of a gene. The Rat1 complex degrades the RNA 
until it physically ‘bumps’ into RNAP II (155). This causes a conformational change in 
RNAP II and subsequent release from the template. Evidence supports both models, 
and the actual mechanism of termination is widely accepted as a combination of both 
(198, 249). 
1.6 TFIIB: STRUCTURE AND FUNCTION 
 Transcription factor TFIIB is a single subunit protein of about 38 kDa size. It is 
required for initiation of transcription as well as start-site selection. The gene, SUA7, 
codes for TFIIB in budding yeast. It was originally discovered in a genetic screen as a 
suppressor of a mutation that led to a downward shift in the transcription initiation site 
(245). SUA7 is an essential gene in yeast that encodes a protein of 345 amino acids. 
Interestingly, the human TFIIB can recruit both human and yeast RNAP II to the 
promoter region, while the yeast TFIIB can only recruit the yeast RNAP II, indicating that 
an important change has occurred in the structure of protein during evolution (289). 
Genetic, biochemical and structural evidence have implicated TFIIB in multiple aspects 
of the RNAP II transcription cycle. It has been shown to play a role in activation, PIC 
formation, start-site selection as well as the termination of transcription (71, 101, 123, 
133). 
 TFIIB consists of two basic domains, an N-terminal zinc-finger domain, and a C-
terminal core domain (Fig 6). The zinc finger domain is known to interact with RNAP II 
and TFIIF, while the core domain interacts primarily with TBP as well as the BRE  
sequences flanking the TATA-box (37, 114, 316). The core domain of TFIIB, spanning 
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residues 120 to 345, is composed of two direct repeats made up of 5 α-helices that are 
22% identical and 42% similar, and are separated by an amphipathic helix extending 
from 184 to 201 residues (71). The species specific region accounting for the human 
and yeast differences has been mapped to 14 residues in the first direct repeat (268). In 
vitro, the TFIIB core domain can bind the promoter independently in the presence of 
TBP, but is incapable of recruiting RNAP II (14). The C-terminal core domain plays a 
crucial role in the initiation of transcription, possibly by helping orient DNA in the 
promoter-proximal region for unwinding.  
 Once the TBP binds the DNA, it bends the DNA by almost 90 degrees (230). The 
bend allows interaction of core TFIIB with the BREs upstream and downstream of the 
TATA box. The DNA downstream of the TATA-box unwinds in the preinitiation complex 
forming the transcription bubble, above the TBP saddle, and the template DNA strand is 
positioned at the RNAP II active site (145, 229). TFIIB forms the bridge between the 
TBP-TATA box complex and the polymerase surface, where the C-terminal core 
interacts with TBP and the N-terminal zing finger makes extensive contacts with Rpb1 
and Rbp2 subunits of RNAP II (48, 85, 162, 195, 332). 
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 Mutational and structural analysis of TFIIB has provided further insight into the 
importance of its N-terminal domain. The zinc finger domain can be broken down into 
three discrete functional units; the B-ribbon comprising residues 17-55, the B-reader 
with residues 56-88, and the B-linker from 89-120 (39, 50, 124, 333). The B-reader is 
immediately distal to the N terminal B-ribbon and is the most conserved TFIIB sequence 
known (71). It plays a crucial role in start-site selection (123, 187, 239, 246, 330). Two 
of the key alleles of SUA7, sua7-1 and sua7-3, which exhibit altered start site selection, 
were the consequence of mutations E62K and R78C respectively, mapped to the B-
reader (246). In addition to start site selection, these mutations also give rise to a cold-
sensitive phenotype for which suppressors have been isolated. Suppressors of 
mutations in this domain were found in TFIIF and RNAP II subunits(277, 278). The 
structural studies further confirmed the interaction of B-finger with TFIIF and polymerase 
subunits (126). Surprisingly, an enhancer of a mutation in the B-reader was found in 
Ssu72, a 3' end processing/termination factor (278). 
 Structural studies have revealed that TFIIB makes contact with the active site of 
RNAP II in the initiation complex (40). The zinc ribbon domain first contacts RNAP II at 
the dock domain (40). The residues 20-54 of the zinc ribbon form three antiparallel -
strands, which surround a zinc ion (Fig. 7). The zinc ribbon domain contacts the RNAP 
II at Rpb1 residues 409-419, near the RNA exit channel of the polymerase (16, 37, 114, 
133, 321). The TFIIB reader domain passes through the saddle region of RNAP II, 
between the clamp and the wall, and inserts into the active center of the enzyme (40). 
From there, it extends down to the base of the cleft, and then comes up and exits. In 
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addition, the B-finger and core also make multiple contacts with TFIIF, which is located 
near the RNA exit channel (41, 94, 126, 200). 
 
 
TFIIB is essential for initiation of transcription, but immediately after initiation, its 
zinc-finger becomes inhibitory for elongation of transcript as it competes with the 
growing RNA chain for occupancy of the polymerase saddle region and the exit channel 
(238). To allow transcription to proceed further, the zinc finger is ejected from the exit 
channel after RNAP II has transcribed first 10-11 nucleotides. This results in the 
separation of TFIIB from RNAP II and possibly from the promoter region. In vitro studies 
have clearly demonstrated the release of TFIIB from the initiation scaffold soon after 
initiation of transcription (325).  
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In keeping with its vital role in transcription initiation, TFIIB has been found to 
interact both physically and genetically with other components of PIC such as TFIID, 
TFIIH and Mediator complex as well as the transcription regulators such as activators 
and repressors. TFIIB has been shown to physically interact with TFIID subunits TAF1, 
TAF9, TAF10 and TAF12 in the TFIID-TFIIA-TFIIB complex formed on the promoter 
during PIC formation (114, 117, 258). TFIIB exhibits physical as well as genetic 
interaction with the TFIIH subunits Tfb4 and Ssl2 (105, 295). Mediator subunits Srb2, 
Srb5, Srb6 and Rgr1 have been found co-fractionating with TFIIB during 
chromatographic purification (197, 325), while  interaction with Med15 subunit was 
shown in a split-ubiquitin screen (190). 
Reconstituted transcription using purified GTFs, RNAP II and Gal4-VP16 fusion 
protein led to the discovery of a novel role of TFIIB in activation of transcription (191, 
192). Work from multiple labs has since confirmed the transcription activation function of 
TFIIB. In keeping with its role in activation, interaction of TFIIB with a number of acidic 
activator proteins has been demonstrated in vitro (71). Most activators have been 
shown to interact with the amphipathic helix connecting the two direct repeats in the 
TFIIB core domain (1, 45, 172, 186, 316). However, there are some such as VP16 that 
interact with the direct repeats (192). A direct physical interaction of TFIIB with the Gal4-
VP16 activator protein has also been demonstrated in vivo using the crosslinking 
approach (117). This is the only known case of a direct physical interaction of TFIIB with 
an activator under physiological conditions. In humans, thyroid hormone receptor beta 
(THRβ) can function as an activator or repressor depending on whether or not thyroid 
hormone is present. It was found that THRβ physically interacts with the N-terminal of 
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TFIIB without its hormone ligand and represses transcription. Upon binding of hormone, 
THRβ interacted with the TFIIB core domain and activated transcription (15). 
 TFIIB exists in two conformations, an ‘open form’ where the N and C-termini are 
free to interact with other proteins, and a ‘closed form’ where the N-terminal physically 
interacts with the second repeat of the C-terminal core (Fig. 8) (14, 101, 122, 124, 250, 
317, 331). It has been reported that activators binding to TFIIB induces a change in its 
conformation (1, 124, 250, 316). In addition, TFIIB binding to BREs cause a 
conformational change that is important for start-site selection (90). Less well known is 
the fact that TFIIB can acetylate itself in the presence of acetyl-CoA on Lys238. The 
acetylation is important for stabilizing TFIIB-TFIIF interaction, and for transcription in 
vitro (54). 
1.7 TFIIH: STRUCTURE AND FUNCTION 
 Transcription Factor TFIIH is a complex of 11 subunits with a molecular mass of 
over 500 kDa(224). Apart from Mediator, it is the only GTF with two separate enzymatic 
activities: a DNA helicase and a kinase activity (110). TFIIH was discovered in 1989 in 
Conaway laboratory when they purified a factor from rat liver that was required for 
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accurate transcription initiation and was characterized by an ATPase activity that was 
stimulated by the TATA-box (62-64). Structurally, TFIIH can be divided into two 
modules: the core module (subunits Ssl1, Ssl2, Rad3, Tfb1, Tfb2, Tfb4, Tfb5 and Tfb6) 
and kinase module also known as TFIIK in yeast (subunits Tfb3, Ccl1 and Kin28) (61, 
224). Sequencing and structural analysis strongly suggest the evolutionarily conserved 
nature of the factor. Electron microscopy (EM) and crystal structure found TFIIH a ring 
like structure where TFIIK is linked to the core through Rad3 (Fig. 9) (92, 99, 247, 280). 
The conserved enzymatic activities reside in the Ssl2 and Rad3, 
which are 3’ to 5’ and 5’ to 3’ ATP-dependent helicases respectively; and Kin28 which is 
a serine kinase that phosphorylates CTD of Rpb1(61). In yeast, the Ssl1 subunit has 
also been found to contain an E3 ubiquitin ligase activity that functions in the 
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transcriptional regulation of genes involved in DNA repair (281). Apart from its essential 
function in transcription, TFIIH has also been found to play a crucial role in the repair of 
DNA by nucleotide excision repair (NER) pathway. A few studies have also implicated 
TFIIH in RNAP I transcription (13, 33, 77, 139, 260). 
 During transcription, the enzymatic activities of TFIIH play key roles in 
stabilization of PIC and in promoter escape (308). TFIIH is the last GTF to be recruited 
onto the promoter during PIC formation. It is not necessary for transcription in an in vitro 
transcription system when the template DNA is either supercoiled or partially melted 
near the TATA-box (135, 242). The core module forms a ring like structure that 
positions the Ssl2 helicase at the leading edge in front of the PIC and RNAP II, and the 
Rad3 helicase behind RNAP II. It is through this positioning that both helicases could 
function where Ssl2 will unwind the DNA in 3’ to 5’ direction from the leading edge 
toward RNAP II while Rad3 may unwind from the back in 5’ to 3’ orientation, melting the 
DNA and extending the transcription bubble with RNAP II (99). However, it is only the 
Ssl2 helicase activity that is required for formation of the open complex where 10 bp of 
DNA is melted just downstream of the TATA box (56, 57). Recent work indicates that 
Ssl2 may not function in the PIC as a 3’ to 5’ helicase and instead works as a DNA 
translocase. It was found that Ssl2 binds downstream of the bubble and may insert 15 
bp of unwound DNA into the RNAP II active site (57, 111, 157).The requirement of Ssl2 
helicase continues during initiation until the bubble reaches 17-18 bp and collapses 
back down to 10 which is the size during elongation (238).  
 The exact contacts that different subunits of TFIIH make during PIC formation 
are not well understood as the structural studies on TFIIH are not of high enough 
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resolution to map them into the RNAP II EM densities. Recently, Tfb6 was identified as 
the 11th subunit of TFIIH. It was found that Tfb6 interacts with Ssl2 and this interaction 
dissociates Ssl2 from TFIIH holoenzyme upon Tfb6 phosphorylation. Tfb6 is not an 
essential protein and purification of TFIIH from a Tfb6 deleted strain resulted in a 20 fold 
increase in yield of holo-TFIIH complex (224).   
 TFIIH kinase activity is stimulated by interactions with TFIIE, TFIIF and the 
Mediator along with the U1 snRNA (22, 88, 171, 233, 236). TFIIK phosphorylates RNAP 
II CTD at both serine-5 and serine-7 in the open complex, although in yeast it is unclear 
exactly where this happens in vivo as RNAP II scans downstream for about 20- 200 bp 
in order to find a TSS, which is well past the size of the bubble (3, 103, 199). This is in 
contrast to mammalian cells, where TSS is generally located 23-28 bp downstream of 
the TATA-box (86). The CTD phosphorlyation signals promoter escape and also breaks 
the contacts of Mediator head module with RNAP II CTD. The serine-5 phosphorylation 
mark then signals the recruitment of the capping machinery (53, 89). After the first 
round of initiation, TFIIH remains on the scaffold with TFIID, TFIIA and TFIIE in the 
presence of an activator in order to drive further rounds of reinitiation (325).  
1.8 CTD PHOSPHORYLATION 
 The largest subunit of RNAP II, Rpb1, contains a region towards the C-terminus 
called the carboxy-terminal domain (CTD), which consists of multiple repeats of the 
heptapeptide sequence Y1S2P3T4S5P6S7. Since its discovery in 1985, it has been a focal 
point of research (65, 66). The CTD repeats are highly conserved in sequence yet vary 
in number from organism to organism. There are 26 repeats in yeast, 46 in flies and 52 
in human (35, 65). Deletion of the CTD is lethal in vivo, but not required for in vitro 
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transcription (231, 232, 328). The CTD is the target for many post translational 
modifications. Five of its seven residues, tyrosine-1, serine-2, threonine 4, serine-5 and 
serine-7, can be phosphorylated (Fig. 10). In addition, the proline residues at 3 and 6 
can be isomerized into stable cis and trans configurations (81).  In order to better 
understand the possible syntax of the CTD, research done in the Stiller and Shuman 
laboratories placed additional residues at key places throughout the CTD (193, 263, 
276). 
The results indicate that the CTD is actually composed of 11 residues long functional 
units, which comprises the first heptad and the next four residues in the chain (81, 194, 
262, 276). Taken together, it would appear that the overall length of the CTD is 
important, along with keeping functional units intact with respect to tyrosine and serine-
proline-serine spacing. In yeast, with 26 repeats, the overall length of an unordered 
CTD tail could stretch up to 900 Ao, which is nearly 6 times the diameter of RNAP II; 
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making it an ideal scaffold to recruit factors that need to physically interact with RNAP II 
over a variety of its surface during transcription and cotranscriptional RNA processing 
(81). 
 The enzymes responsible for most of the CTD posttranslational modifications 
have been discovered. In yeast, there are four known enzymes for phosphorylating the 
CTD: Kin28, Srb10, Ctk1 and Bur1. Kin28 is a subunit of TFIIH that performs serine-5 
and ser7 CTD phosphorylation (103, 156). Srb10 is a subunit of Mediator and has been 
shown to phosphorylate serine-2 and serine-5 in vitro (127, 188). Ctk1 is a subunit of 
the elongation complex and is thought to perform the majority of serine-2 
phosphorylation (52). Bur1 functions during elongation as part of the Bur1-Bur2 cyclin-
dependent kinase complex and phosphorylates serine-2 and serine-5 in addition to 
phosphorylating the elongation factor Spt5 (309). In budding yeast, three more kinases 
that could possibly target the CTD have been identified on the basis of their 
phosphorylation target similarity with known CTD kinases. These are Brd4, Erk1 and 
Erk2 (81). It is thought that Brd4 may be a yet another kinase that may target serine-2. 
The CTD phosphorylation at tyrosine-1 and threonine-4 residues was recently 
demonstrated in yeast. However, identification of the kinases responsible for these 
modifications remains elusive (47, 130, 137). The prolyl-isomerase, Ess1, preferentially 
targets the proline-6 residue when serine-5 is phosphorylated and has been shown to 
be involved in initiation and termination of transcription (119, 163). 
 The serine phosphatases that remove CTD mark are well characterized. Ssu72, 
which is a component of the cleavage and polyadenylation factor (CPF) complex, 
removes serine-5 and serine-7 marks (19, 95, 165). Ssu72 is recruited at the promoter 
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and the terminator regions of a gene and is believed to function at both the ends of a 
gene (10). Cdc14 removes both serine-2 and serine-5 marks and functions during 
mitosis where it is required for mitotic exit (55). Rtr1 is a serine-5 phophatase that has 
been shown to function during the transition from initiation to elongation (220). Fcp1 is a 
serine-2 phosphatase which is also recruited at the promoter and terminator regions, 
but is only thought to function at the terminator (160). 
 Early ChIP experiments using some of the first antibodies to recognize CTD 
phosphorylation began to paint the picture of a CTD code that could be used to tell the 
position of RNAP II along a gene. In this now widely accepted model for protein coding 
genes, serine-5 phosphorylation peaks over the TSS and fades along a gene in a 
fashion opposite to that of serine-2 phosphorylation which starts downstream of the 
promoter and peaks over the poly(A)-site (Fig. 11) (35). Tyrosine-1 and threonine-4 
phosphorylation remains at high levels throughout the coding region between the 
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promoter and the terminator. Serine-7 phosphorylation exhibits a similar pattern, except 
that it extends a little bit more into the promoter and terminator regions (81). The CTD 
phosphorylation pattern over a gene signals the stage of transcription of a gene.  The 
initiation factors, such as Mediator and TFIIH, involved in PIC assembly, recognize 
hypophosphorylated CTD (158, 308). A notable exception is that some of the 
termination factors, such as Pcf11 and Ssu72, thought to be recruited through serine-2 
phosphorylation at the terminator, are also recruited onto the promoters (6, 266). 
 More recently, numerous genomewide data sets have attempted to analyze this 
problem with new monoclonal antibodies that can better detect specific CTD 
phosphorylation patterns. These studies have revealed that different genes exhibit 
different patterns of CTD phosphorylation during transcription. A recent study found that 
the pattern of CTD phosphorylation differed on genes depending on their transcriptional 
activity and their isolation within the genome (286). Some genes displayed a more or 
less uniform serine-2, serine-5, and serine-7 phosphorylation pattern throughout the 
gene body. In contrast, some have only 5’ or 3’ phosphorylation peaks, while others 
have both 5’ and 3’ peaks of a particular modification. For example, some genes display 
a uniform serine-7 phosphorylation pattern throughout the gene, while a number of 
genes exhibit only the 5' enrichment (286). For the serine-5 phosphorylation mark, most 
genes displayed only a 5' peak, while some showed a peak at both the 5' and 3' ends.  
Regarding the serine-2 phosphorylation mark, while most genes conformed to the usual 
model with a 3’ peak, they did find those that either had uniform or 5’ peak distributions 
(286). 
1.9 PROMOTER-TERMINATOR CROSSTALK 
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 The transcription cycle can be divided into three basic steps: initiation, elongation 
and termination. Each of these steps requires a unique set of factors for its proper 
execution. The generally accepted view is that the transcription factors have exclusive 
roles dedicated to a particular step in the transcription cycle. The current body of 
evidence suggests that the different steps of the transcription cycle do not operate in 
isolation, but rather integrate into each other (167, 203, 212, 266, 297). This may seem 
intuitive for sequential steps where some initiation factors also participate in elongation, 
as the subsequent elongation step relies on completion of initiation. However, evidence 
suggests that the initiation factors may function in termination, and termination factors 
similarly help in initiation of transcription (6, 115, 207, 212, 221, 329). This promoter-
terminator crosstalk is poorly understood, and it is not known how these functional 
relationships can influence the transcription cycle. 
 There are a number of factors operating at the promoter region of eukaryotic 
genes that physically or functionally communicate with the terminator-bound factors 
(Table 1). TFIIB, for example, interacts with a number of termination factors. These 
include both genetic and physical interactions. The first evidence regarding this  
TABLE 1 Promoter bound factors which interact genetically or physically with 
terminator bound factos 
Promoter 
bound 
Factor 
Protein / 
subunit 
Terminator 
bound Factor 
Interacting 
partner/subu
nit 
Type of 
interaction 
Reference 
TFIID Taf2  
 
CPF Ssu72, Fip1, 
Cft2, Cft1, 
Mpe1, Ref2, 
Ysh1, Pta1, 
Pap1 
Affinity-MS Sanders et al., 
2002 
 Taf5 
 
CPF Cft1 Affinity-MS Lee  et al., 
2011 
27 
 
 
 
 Taf6 
 
3'-end RNA-
processing 
complex 
Pab1 Affinity-MS Sanders et al., 
2002 
 Taf6 
 
CF1 Rna14 Affinity-MS Gavin  et al., 
2002 
  Taf8, Taf12 Rat1 complex Rtt103 (-) Genetic Constanzo et 
al.,  2010 
 Taf9 CPF Ref2 Synthetic lethal Milgrom  et al., 
2005 
 Taf14 Isw1b Ioc2 (+) Genetic Collins et al.,  
2007 
TFIIB TFIIB CPF Ssu72 Phenotypic 
enhancement, 
Synthetic rescue 
Sun and 
Hampsey  1996 
 TFIIB CPF Ssu72 Dosage rescue, 
Synthetic lethal 
Wu et al., 1999 
 TFIIB CPF Ssu72 Reconstituted 
complex 
Wu  et al., 1999  
 TFIIB CPF Ssu72 Affinity-Western Ganem et al.,  
2003 
TFIIH Rad3 CF1 Rna14 Synthetic rescue Jensen et al., 
2004 
 Ssl1 Rat1 complex Rtt103 (-) Genetic Constanzo et 
al.,  2010 
 Kin28 CPF Ssu72 Affinity-Western, 
Synthetic lethal 
Ganem  et al., 
2003 
Mediator Med8 Rat1 complex Rtt103 (-) Genetic Constanzo et 
al.,  2010 
 Rox3 (3'-end RNA-
processing) 
Yra1 Affinity-MS Krogan  et al., 
2006 
 Srb2 CPF Ssu72 (-) Genetic Constanzo  et 
al., 2010 
 Med1 CPF Syc1 (-) Genetic Wilmes et al.,  
2008 
 Soh1 CPF Ssu72 (-) Genetic Collins et al.,  
2007, Fielder et 
al.,  2009 
 Soh1 CPF Syc1 (-) Genetic Wilmes et al.,  
2008 
 Soh1 Rat1 complex Rtt103 (-) Genetic Wilmes  et al., 
2008 
 Gal11 CPF Swd2 (-) Genetic Collins  et al., 
2007 
 Gal11 Rat1 complex Rtt103 (-) Genetic Collins  et al., 
2007 
 Pgd1 Rat1 complex Rtt103 (-) Genetic Collins  et al., 
2007 
 Pgd1 Isw1b Ioc4 (+) Genetic Collins  et al., 
2007 
 Cse2 CPF Syc1 (-) Genetic Wilmes  et al., 
2008 
 Sin4 Rat1 complex Rtt103  (+) Genetic Costanzo  et 
al., 2010 
 Sin4 Isw1b Ioc2 (-) Genetic Costanzo  et 
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al., 2010 
 Srb5 CF1 Rna15 Affinity-Western Mukundun et 
al., 2013 
SAGA Gcn5 CPF Ysh1 Affinity-MS Graumann et 
al.,  2004 
 Ada2 CF1 Pcf11 2 Hybrid Uetz  et al., 
2000 
 Ahc1 Isw1b Ioc4 (-) Genetic Costanzo et al., 
2010 
 Spt8 CF1 Rna14 Synthetic growth 
defect 
Holbien et al., 
2009 
 Spt8 CPF Pti1 (-) Genetic Collins  et al., 
2007 
 Spt8 CPF Ssu72 (-) Genetic Collins  et al., 
2007 
 Spt8 CPF Pta1 (-) Genetic Collins  et al., 
2007 
 
 Ubp8 Rat1 complex Rtt103  Synthetic rescue Hang et al., 
2011 
 Spt3 CPF Pta1 (-) Genetic Collins  et al., 
2007 
 
 Spt3 CPF Pti1 (-) Genetic Collins  et al.,  
2007 
 Spt3 Rat1 complex Rtt103  (-) Genetic Collins  et al., 
2007 
 Chd1 Isw1b Ioc2 (-) Genetic Collins  et al., 
2007 
 Chd1 Isw1b Ioc4  (-) Genetic Costanzo et al.,  
2010 
 Ngg1 3'-end RNA-
processing 
complex 
Pab1 Affinity-Western Drysdale et al., 
1998 
 Sgf29 CPF Pta1 (-) Genetic Costanzo  et 
al., 2010 
 Hfi1 Isw1b Ioc2 (-) Genetic Collins et al.,  
2007 
 Spt7 CPF Cft1 Affinity-MS Lee et al.,  
2011 
 Sus1 (3'-end RNA-
processing) 
Yra1 Affinity-Western Pascual-Garcia 
et al., 2008 
 Sus1 (3'-end RNA-
processing) 
Yra1 Synthetic lethal Rodriguez-
Navarro et al.,  
2004 
 Sgf73 CF1 Pcf11 (+) Genetic Costanzo et al.,  
2010 
came from a genetic screen for factors important for initiation. A point mutation (E62K) 
in the B-finger region of yeast TFIIB (sua7-1) altered transcription start site selection 
and conferred a cold-sensitive growth phenotype (246). A mutation in Ssu72 (ssu72-1) 
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enhanced this defect by shifting the start site further downstream and conferring a heat-
sensitive phenotype (278). Yeast proteomic analysis identified Ssu72 as a subunit of the 
CPF complex (72, 97, 125, 274). In addition to the genetic interaction, TFIIB and Ssu72 
also exhibit a physical interaction in vitro (317). These observations raised the intriguing 
possibility that TFIIB could be making additional contacts with the components of the 3’ 
end processing machinery during transcription. These studies strongly suggested a role 
for TFIIB at the 3′ end of genes, and will be the focus of investigation in Aim# 1 of my 
thesis.   
 In addition to TFIIB, there are also reports of TFIIH interaction with termination 
factors (Table 1). Several subunits of TFIIH have been found  physically and functionally 
interacting with the 3′ end associated factors. Kin28, which is the kinase subunit of 
TFIIH, interacts physically as well as genetically with Ssu72 (67, 97, 115, 165). The 
TFIIH-Ssu72 interaction as well as phosphorylation-dephosphorylation of serine-5 and 
serine-7 contribute to successful execution of the transcription cycle and will be 
discussed later in this chapter in the context of Ssu72. In addition to the Kin28-Ssu72 
interaction, Ssl1 subunit was found to exhibit a genetic interaction with Rtt103 subunit of 
Rat1 complex, which is involved in termination of transcription (67, 155). The role of 
these interactions and TFIIH kinase activity at the 3’ end of genes will be the focus of 
investigation in Aim# 2. 
 Mediator is another promoter-associated factor that exhibits interaction with the 
terminator-bound factors. The first evidence that Mediator could be contacting the 
termination factors came from a large scale yeast proteomic analysis (58). This study 
identified interaction of one of the head subunits, Rox3, with Yra1, a protein involved in 
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3′ end processing and mRNA export (Table 1). All other Mediator-termination factor 
interactions that have been reported so far are from the widely used ‘Epistatic Miniarray 
Profile’ (E-MAP) technology, which measures genetic interactions based on the pair-
wise deletion of genes that have been linked to specific biological processes. This 
synthetic genetic approach established interaction of the head subunit, Med8, with 
Rtt103 (58), and identified further interaction of middle and tail submodules with the 
CPF subunits (Table 1) (58, 67, 306). Recently, Srb5 subunit of Mediator head module 
was also found interacting with the Rna15 subunit of CF1A complex (221)(Mukundan 
and Ansari, 2013). 
 The overwhelming evidence of the interaction of the promoter and terminator-
bound factors in the cell raises an important question. What is the significance of such 
interactions in the context of the transcription cycle? A clue came from crosslinking 
studies of the factors on transcriptionally active genes. The chromatin 
immunoprecipitation (ChIP) analysis of formaldehyde-crosslinked cells revealed that the 
initiation and termination factors are not merely interacting with each other, but they are 
also interacting with the distal ends of genes (Fig. 12). TFIIB, for example, has been 
found occupying both the 5′ and 3′ ends of genes during transcription (83, 209, 210, 
212, 225, 270, 293). A genomewide analysis revealed that about 80% of a selected 
group of 1140 transcriptionally active genes in yeast have TFIIB localized at both ends 
(225). The TFIIB signal at the 3′ end, however, was 2-times less than that on the 5′ end. 
The crosslinking of TFIIB to the extremities of genes during transcription is an 
evolutionarily conserved feature, being observed in humans as well (207, 323). A similar 
gene occupancy profile has been observed for TBP, both in yeast and humans (207, 
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225). Mediator subunit Srb5, TFIIF subunit Tfg1, as well as TFIIH subunits; Ssl2 
and Kin28, also occupy the distal ends of a gene in a transcription-dependent fashion 
(105, 210, 221, 248, 329). The transcription-dependent interaction of so many initiation 
factors with the 3′ end strongly suggests a biological role for these factors at the 
terminator end of genes. 
 Analogous studies with the termination factors found them localized to the 3′ end 
as expected, but a number of them were also found occupying the 5′ end of genes (Fig. 
12). The subunits of both CF1 and CPF complexes in yeast exhibited the transcription-
dependent crosslinking to gene boundaries (10, 43, 155, 212, 227). A similar 
localization of CPSF and CstF subunits at the ends of genes was observed in 
mammalian systems (102, 297). Recently, crosslinking of two termination factors, TTF2 
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and Xrn2, to the 5′ end of genes was reported in mammalian cells (34). The homologue 
of Xrn2 in yeast is Rat1. Both Rat1 and Xrn2 are believed to facilitate termination of 
transcription by the torpedo mechanism (155, 302). The Rat1 and its associated factor 
Rai1 also occupy both ends of genes during transcription (155). 
 One possible explanation for termination factors occupying the promoter region 
arose from the recent discovery of wide spread promoter driven upstream anti-sense 
transcription (240, 264, 265). Many of these short anti-sense transcripts were found to 
be cleaved and polyadenylated poly(A) signals (7). Interestingly, the U1 signals were 
found to be enriched in the sense direction relative to the poly(A); and the disruption of 
U1 snRNP activity resulted in the premature termination in the sense direction (7). Thus, 
the interaction of the initiation and termination factors is not merely the coincidental co-
recruitment to the distal ends of a gene, but indicates a functional relationship that 
confers directionality to the promoter-bound polymerase and also influences overall 
transcription of a gene. Another possible interpretation of this evolutionarily conserved 
transcription factor occupancy pattern on gene extremities is that the initiation and 
termination factors may physically interact with each other on the chromatin template 
during transcription to form a gene loop that enhances efficiency of transcription. 
1.10 GENE LOOPING 
 The ChIP data, along with the physical interaction data and the genetic analysis, 
have provided unequivocal evidence in support of the interaction of a number of 
initiation and termination factors with both the ends of a gene. A critical issue is how the 
initiation and termination factors that are expected to occupy the 5′ and 3′ ends 
respectively of a gene, are able to contact both ends of a gene. There are two possible 
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explanations for this rather unexpected distribution of transcription factors. One 
possibility is that these factors are recruited independently to both ends of a gene. The 
other possibility is that the presence of a factor at the two ends of a gene is the result of 
gene looping (102) (Fig. 13). When a gene is in looped 
conformation, the close proximity of the promoter and terminator regions may facilitate 
the interaction of a promoter-bound factor with the terminator region, and that of a 
terminator-associated factor with the promoter. There is a high probability that the same 
molecule simultaneously contacts both ends of a looped gene (270). In such a scenario, 
the molecules occupying the promoters and terminators are not separate entities (Fig. 
13). There is experimental evidence to support both possibilities (23, 102, 173, 207, 
221, 270, 293). 
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 A number of genes in yeast undergo looping in a transcription-dependent manner 
(6, 10, 23, 83, 102, 141, 217, 270, 283, 284). Chromatin analysis using the 
chromosome conformation capture (CCC) approach revealed that gene looping is due 
to the juxtaposition of the promoter and terminator regions of a gene (Fig. 13). When a 
gene is in looped conformation, TFIIB localizes to both ends of the gene (83, 270). 
Gene looping is completely abolished in the sua7-1 mutant (E62K) of TFIIB in budding 
yeast. This is the same mutant that led to the discovery of one of the first known 
interactions of a promoter-bound factor with a terminator-linked factor, that of TFIIB with 
Ssu72 (102, 278). In this mutant, the recruitment of TFIIB at the promoter region 
remains unaffected, but its crosslinking to the 3′ end of a gene is almost completely 
abolished (270). Accordingly, TFIIB-interacting termination factors were observed at the 
5′ end of a gene in wild type cells, but not in the looping defective sua7-1 cells (6). 
Although the concept of gene looping is not so well established in higher eukaryotes, 
analogous studies have found evidence of genes assuming a looped architecture during 
transcription in mammalian systems as well (141, 179, 234, 243, 282, 326).  There are 
also reports of transcription dependent gene looping in Drosophila and plants (70, 128). 
Gene looping explains localization of at least some transcription factors at the distal 
ends of a gene. The crosslinking of TFIIB, Mediator subunit Srb5 as well as TFIIH 
subunits; Ssl2 and Kin28 to both the ends of a gene in yeast occurs in a looping 
dependent manner, and therefore can be attributed to gene looping (83, 105, 210, 221, 
248, 270, 329). Similarly, a number of CF1 and CPF subunits in yeast also crosslink to 
the promoter region in a looping-dependent manner (6, 10, 43, 155, 212, 227). 
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 Gene looping, however, may not account for the interaction of all initiation and 
termination factors with the ends of genes. A substantial number of yeast genes exhibit 
anti-sense transcription initiating from their 3′ end (49, 228, 318). The genes with 
detectable 3' end initiated anti-sense transcripts display a promoter-like architecture at 
their 3′ end (225). Genomewide analysis revealed that a majority of such genes have 
TFIIB and TBP present at their 3′ end (225). Whether these genes assume looped 
conformation during anti-sense transcription remains to be elucidated, but at least some 
of them display anti-sense transcription as well as the TFIIB-TBP occupancy at the 3′ 
end in the absence of gene looping (225). The interaction of TFIIB and TBP with the 3′ 
end of genes in linear conformation, therefore, cannot be attributed to gene looping, but 
to the independent recruitment of these factors at the 3′ end of genes. 
 The physiological significance of gene looping has been recently demonstrated in 
a few key studies. First, gene looping was found to play a role in transcriptional 
memory, which is the process where the transcriptional machinery ‘remembers’ a 
previously activated state via gene loop formation, and thus the cell can respond much 
faster during reinduction (173, 283). Second, gene looping was linked to promoter 
directionality, where promoter driven anti-sense transcription decreased during gene 
loop formation (44, 284). Third, the intron-mediated enhancement of transcription (IME) 
has been found to require gene loop formation, and the addition of an intron to the 5’ 
proximal coding region can activate a gene and force a looped conformation (217). 
Fourth, gene looping helps in activator dependent enhancement of transcription by 
facilitating reinitiation (6, 83). Last, gene looping has also been shown to facilitate 
termination of transcription, possibly through the poly(A) site selection (6). 
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1.11 RESEARCH FOCUS 
 While the prevalence and physiological significance of gene looping has been 
demonstrated over the last decade; the mechanism that physically links the promoter 
and terminator regions in order to form a gene loop is poorly understood. It is 
hypothesized that gene loops form due to the interaction of promoter and terminator 
bound factors. Namely, the general transcription factors (Mediator, TFIID, TFIIA, TFIIB, 
TFIIF and TFIIH) would physically and functionally interact with the termination factors 
(CF1 and CPF). In order to investigate if that is the case, my research focused on two of 
the general transcription factors: TFIIB and TFIIH. 
 TFIIB was an excellent candidate based on its localization on the terminator 
during transcription, its genetic interaction with the termination factor Ssu72 and the loss 
of gene looping in the mutant of TFIIB, sua7-1. In chapter II, my research focuses on 
investigating the molecular basis of gene loop formation through the isolation of a gene 
looping complex with TFIIB. Genome wide studies have also demonstrated that in 
addition to TFIIB, TFIIH localizes on the terminator (248, 292, 294). In chapter II, my 
research investigates a role for TFIIH in the termination of transcription and gene loop 
formation. In addition, I further demonstrate that these roles are dependent on the 
kinase function of TFIIH subunit, Kin28. 
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CHAPTER II 
EVIDENCE FOR A HOLO-TFIIB COMPLEX CONTAINING TERMINATION FACTORS 
THAT FACILITATE GENE LOOP FORMATION 
 
Most of this chapter has been published:  
Medler et al., (2011) Evidence for a Complex of Transcription Factor IIB (TFIIB) 
with Poly(A) Polymerase and Cleavage Factor 1 Subunits Required for Gene 
Looping. J Biol. Chem. 286:33709-18. DOI: 10.1074/jbc.M110.193870 
 
II.1. ABSTRACT 
 Gene looping is emerging as an important gene regulatory mechanism in 
eukaryotes. The presence of general transcription factors at the promoter region of a 
gene during transcription is well established. However, recent studies have revealed the 
localization of the general transcription factor TFIIB to the 3’ end of a gene as well 
during transcription. Here we show that TFIIB localization at the terminator end of a 
gene requires a functional CF1 complex. TFIIB physically interacts with the all subunits 
of the CF1 complex. Affinity chromatography and sedimentation analysis revealed the 
existence of a holo-TFIIB complex consisting of Pap1 and CF1 subunits. This complex 
was resistant to MNase digestion suggesting that the interaction of TFIIB with 
termination factors was not mediated by RNA or DNA. The complex was also stable 
upon brief exposure to high salt. The sedimentation coefficient of the holo-TFIIB 
complex was similar to that of large ribosomal subunit, and was intermediate between 
that of TFIIH and TFIID. The general transcription factors TFIID and TFIIH as well as 
subunits of RNAP II could not be detected in the affinity-purified holo-TFIIB preparation. 
The holo-TFIIB complex was observed only in the looping competent strains, but not in 
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the looping defective sua7-1 strain. We further show that in sua7-1 cells, where a holo-
TFIIB complex is not formed, the kinetics of activated transcription are altered. These 
results strongly suggest a role for the holo-TFIIB complex in gene looping, and a 
possible role of gene looping in activator-dependent transcription.  
II.2. INTRODUCTION 
Transcription of protein encoding genes by RNA polymerase II (RNAP II) 
involves several distinct steps that include the assembly of preinitiation complex, 
initiation, elongation, termination, and reinitiation (115, 310). Transcription starts with 
the recruitment of RNAP II and the general transcription factors TFIID, TFIIB, TFIIA, 
TFIIF, TFIIE, and TFIIH onto the promoter to form a preinitiation complex (PIC) in 
response to a signal. Gene specific activators respond to the signal by facilitating the 
assembly of PIC. RNAP II and general transcription factors are sufficient for accurate 
basal level transcription at least under in vitro conditions (252, 314). The response to 
activators requires additional cofactors that include chromatin modifiers and Mediator 
complex. Once the gene is activated, the amount of transcripts produced is determined 
primarily by the number of reinitiation events (74). Despite the remarkable progress 
made in understanding the molecular mechanisms that govern initiation of transcription 
in eukaryotes, relatively little is known about the processes that mediate reinitiation. It 
was hypothesized that efficient transfer of polymerase from the terminator to the 
promoter is facilitated by a DNA loop between distal ends of the transcribed gene (74, 
169). The existence of such gene loops has been recently reported for RNAP II-
transcribed genes in yeast, plants and mammalian cells (10, 234, 235, 243, 282). It has 
been shown that RNAP II-dependent gene looping is the consequence of the physical 
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interaction of the terminator with the promoter of the same gene during transcription. 
Gene looping has been shown to require both the cis acting poly(A) termination signal 
and the trans acting 3’ end processing/termination factors (10, 243). The general 
transcription factor TFIIB, which exhibits a genetic interaction with the CPF subunit 
Ssu72, was also found essential for gene looping in yeast (270). Whether termination 
factors and TFIIB facilitate transfer of RNAP II from the terminator to the juxtaposed 
promoter is not known.  
The emerging ubiquity of gene looping and its potential as an important 
transcription regulatory mechanism necessitates understanding the mechanism of gene 
loop formation. Our hypothesis is that the looped architecture is formed by the 
interaction of promotre-bound factors with the factors occupying the 3' end of the gene. 
The preliminary results produced in our laboratory and the published reports have 
identified TFIIB is an important determinant of gene looping. We therefore searched for 
the TFIIB interacting termination factors in this investigation. We believe that a 
macromolecular complex containing TFIIB and the termination factors may serve as a 
bridge between the promoter and the terminator regions during gene loop formation.  
II.3. RESULTS 
II.3.1. ACTIVATORS INTERACT WITH TFIIB DURING ACTIVATED TRANSCRIPTION 
Activators bring about enhancement of transcription. Recent evidence from our 
laboratory suggests that the activator-dependent stimulation of transcription is 
dependent on gene looping. However, activators do not interact with the 3′ end of the 
gene during loop formation (83). These results imply that the activators may be 
facilitating gene looping by recruiting other factors that interact with both the 5' and the 
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3' ends of a gene. We have also shown that TFIIB is an important determinant of gene 
looping. These observations suggest that activator may be enhancing transcription 
through TFIIB-mediated gene looping.  
A number of transcription activators in yeast, mammalian systems and plants 
have been shown to physically interact with TFIIB (71). In many of these studies, an 
activator-TFIIB interaction was demonstrated in the absence of transcription. None of 
the studies in yeast demonstrated physical contact of a native activator with TFIIB under 
in vivo conditions. The vast majority of interactions were performed using in vitro protein 
binding assays which demonstrated that the activators were interacting with the two 
direct repeats in the C terminus of TFIIB which also is shown to interact with RNAP II. 
The only in vivo evidence of a physical interaction is the crosslinking of a Gal4-VP16 
fusion construct with TFIIB during induced transcription (117). If the activators bound to 
their UAS site are mediating gene looping through their interactions with TFIIB, we 
expect activator-TFIIB interaction to occur only during activated transcription when the 
gene is in a looped configuration.  
To investigate interaction of TFIIB with activators, we chose Met28, Ino2 and 
Gal4, which are the gene specific activators of MET16, INO1, and GAL1p-BUD3, 
respectively. Transcription of MET16 is regulated by methionine. In the presence of 
methionine, MET16 is transcribed at a very low level. However, upon methionine 
depletion, transcription of MET16 is stimulated by about 5-fold (83). Similarly, 
transcription of INO1, a gene involved in inositol metabolism, is enhanced by about 50-
fold in the absence of inositol in the medium (83). GAL1p-BUD3, as we have shown 
earlier, is almost completely repressed in the presence of dextrose as a carbon source 
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(83). The addition of galactose brings about a 50-fold stimulation of transcription of 
GAL1p-BUD3 (83). All these three genes are in a looped conformation during their 
induced transcriptional state. In the absence of activators, both gene looping and 
enhanced transcription of these genes is severely compromised. 
We therefore performed coimmunoprecipitation with anti-HA antibodies in strains 
with HA-tagged Met28, Ino2, and Gal4. Coimmunoprecipitation was done during 
induced and non-induced states of MET16, INO1, and GAL1p-BUD3 in formaldehyde 
crosslinked cells. There was no interaction of TFIIB with Met28, Ino2, and Gal4 under 
non-induced conditions (Fig. 14, lanes 3, 8, and 13). TFIIB was coimmunoprecipitated 
with the activators only under transcriptionally inductive conditions (Fig. 14, lanes 5, 10, 
and 15). Activator-TFIIB interaction was not mediated by DNA because micrococcal 
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nuclease digestion of DNA did not abolish the interaction (Fig. 14, lanes 4, 9, and 14). 
The complete digestion of chromatin by micrococcal nuclease was routinely checked 
before performing the coimmunoprecipitation (Figure 15). A moderate decrease in Gal4- 
TFIIB interaction was often observed in the absence of DNA. This suggested that Gal4 
may be interacting with TFIIB through DNA under certain conditions. However, a 
reproducible Gal4-TFIIB interaction was always observed in the absence of DNA (Fig. 
14, lane 14). These results demonstrate that an activator-TFIIB interaction occurs 
specifically during activated transcription in vivo. 
II.3.2. TFIIB localization on the terminator region requires Pap1, Rna14 and Pcf11, 
but not Hrp1 
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Having shown the activator-TFIIB interaction during gene loop formation, we next 
investigated how TFIIB is facilitating gene looping. We reasoned that the promoter-
bound TFIIB may be interacting with the factors present at the 3' end of the gene, and 
this interaction will bring the terminator and the promoter in close physical proximity. 
Our reasoning was based on three published results. First, TFIIB is known to exhibit 
genetic interaction with Ssu72, a component of CPF 3’ end processing complex (278).  
Second, it has been recently demonstrated that TFIIB occupies both the promoter and 
terminator regions of PMA1 and BLM10 in an Ssu72-dependent manner (270). Third, 
looping of several yeast genes was abolished in sua7-1, a mutant of TFIIB that is 
defective in gene looping (270). Since TFIIB physically interacts with several gene 
specific activators in a transcription dependent manner, it was therefore a strong 
candidate for the factor mediating activator-dependent gene looping. 
We therefore asked whether TFIIB association with the 3’ end of genes is also 
dependent on termination factors such as Rna15, Rna14, Pcf11, Hrp1 and Pap1. TFIIB 
ChIP was therefore performed for MET16 and INO1 genes in the temperature-sensitive 
mutants of Rna15 (rna15-2), Rna14 (rna14-1), Pcf11 (pcf11-2), Hrp1 (hrp1-5), Pap1 
(pap1-1) and isogenic wild type strains. TFIIB-ChIP was performed under induced 
transcriptional state of a gene at the permissive (25°C) and non-permissive (37°C) 
temperatures of the mutants. TFIIB crosslinked to both the ends of INO1, in the wild 
type strain at 25°C and 37°C during induced transcription (Fig. 16). In contrast, TFIIB 
crosslinking to the terminator was abolished in rna15-2, rna14-1, pcf11-2 and pap1-1 
strains at restrictive temperature (37°C) (Fig. 16), while the crosslinking to the promoter 
remained intact (Fig. 16). Remarkably, TFIIB occupancy of the terminator region of 
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INO1 remained unaffected in hrp1-5 strain following a temperature shift to 37°C (Fig. 
16). 
Identical results were obtained with MET16 (Fig. 17). Thus, Rna15, Rna14, Pcf11 and 
Pap1 are required for interaction of TFIIB with the 3’ end of MET16 and INO1. Hrp1 may 
not be required for TFIIB localization to the terminator regions of genes.    
II.3.3. TFIIB forms a complex with CF1 subunits and Pap1 
TFIIB is an essential general transcription factor (71). Recombinant TFIIB, with a 
molecular weight in the range of 32 to 38 kDa, could complement all functions of native, 
biochemically purified TFIIB in an in vitro transcription assay (113, 204, 244, 288). 
These results suggested that TFIIB is a single polypeptide protein that exists as a 
monomer in solution. There was no evidence of TFIIB being a part of a macromolecular 
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complex containing initiation factors or termination factors or any other protein. To find 
proteins associated with TFIIB under physiological conditions, the proteomic analysis 
was performed employing the TAP-approach (96, 97, 166). Neither a promoter nor a 
terminator-bound factor was detected in the affinity purified TFIIB preparation in the first 
proteomic analysis carried out by Gavin et al., (97). However, in the second analysis, 
poly(A)-binding protein (Pab1) which interacts with the poly(A) tail of mRNA was 
identified as the only 3’ end processing factor interacting with TFIIB (96). The study 
carried out by Krogan et al., found RNAP II subunits and two terminator-bound factors, 
CPF subunit Fip1 and Pab1 interacting factor Pan2, co-purifying with TFIIB (166). The 
absolute requirement of TFIIB in gene looping, crosslinking of TFIIB to both the 
promoter and the terminator regions of a looped gene and its functional interaction with 
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several 3’ end processing/termination factors including CF1 subunit Rna15 (83, 270) 
suggested that a complex of TFIIB and termination factors exist in the cell.  
We therefore investigated if TFIIB forms a macromolecular complex with CF1 
subunits and Pap1 in yeast cells. Our experimental approach involved affinity 
purification of TFIIB followed by detection of CF1 subunits and Pap1 in the purified 
preparation by Western blot. To perform affinity purification of TFIIB, a triple 
hemagglutinin (3XHA) tag was inserted at the carboxy-terminus of TFIIB. Insertion of 
HA-tag did not interfere with the biological activity of TFIIB as both the transcription and 
gene looping of MET16 and INO1 remained unaffected in the tagged strain (data not 
presented). Additionally, a Myc-tag was integrated at the carboxy-terminus of each of 
the five subunits of CF1 complex and Pap1 for their detection by Western blot. Thus, six 
strains were constructed each carrying HA-tagged TFIIB and Myc-tagged version of one 
of the subunits of CF1 complex and Pap1. 
Cell lysates from each of the six strains described above were purified over anti-
HA-agarose beads. Proteins bound to the beads were eluted with HA oligopeptides. 
Western blot analysis of eluates revealed the presence of Rna14 (Fig. 18, lane 3), 
Rna15 (Fig. 18, lane 4), Pcf11 (Fig. 18, lane 5), Hrp1 (Fig. 18, lane 6), Clp1 (Fig. 18, 
lane 7) and Pap1 (Fig. 18, lane 8) in the affinity purified TFIIB preparation. As a control, 
purification was performed from a strain carrying untagged TFIIB. No signal for Rna14, 
Rna15, Pcf11, Clp1, Hrp1 and Pap1 was observed in the absence of HA-tagged TFIIB 
(Fig. 19), thereby confirming that the observed signals were due to the association of 
these factors with TFIIB. MNase digestion of cell lysate prior to affinity purification did 
not disrupt the association of CF1 subunits and Pap1 with TFIIB (Fig. 20, lanes 3 - 8). 
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These results indicate that the interaction of terminator-bound factors with TFIIB is not 
mediated by DNA or RNA. To rule out the possibility that copurification of Myc-tagged 
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CF1 subunits and Pap1 with TFIIB is not due to 
the interaction of the Myc-tag with TFIIB, the 
affinity purification was performed in a strain 
without a Myc-tag on any of the CF1 subunits or 
Pap1. Western blot analysis of affinity purified 
TFIIB, in this case using antibodies specifically 
directed against Pap1 and CF1 subunit Rna15, 
revealed that the interaction of these factors with 
TFIIB is not dependent on the Myc-tag (Fig. 21, 
lane 1). The affinity purification of a holo-TFIIB 
complex described above was performed at KCl 
concentration of 150 mM. To check the stability of the complex, we repeated the 
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purification at 500 mM KCl in the lysis buffer. High ionic strength did not affect the 
association of TFIIB with CF1 subunits and Pap1 during affinity purification (Fig. 22). 
II.3.4. HOLO-TFIIB COMPLEX DOES NOT CONTAIN GENERAL TRANSCRIPTION 
FACTORS 
 TFIIB has been shown to interact, both genetically as well as physically, with 
TBP and RNAP II (71). We therefore checked for the presence of these proteins in the 
affinity purified TFIIB preparation using antibodies directed against TBP and Rpb1 
subunit of polymerase. No signal for either TBP (Fig. 1B, lane 2) or Rpb1 (Fig. 1B, lane 
4) was detected in the TFIIB preparation. We also did not find any evidence for the 
presence of another general transcription factor TFIIH in the affinity purified TFIIB 
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preparation. Western blot analysis using antibodies against TFIIH subunit Kin28 
confirmed the absence of the factor in the TFIIB preparation (Fig. 1B, lane 6). These 
results suggest that the holo-TFIIB complex does not contain the factors that transiently 
interact with it during the transcription cycle. 
II.3.5. HOLO-TFIIB COMPLEX IS NOT OBSERVED IN LOOPING DEFECTIVE CELLS 
 To determine the physiological significance of TFIIB-CF1-Pap1 complex in the 
context of gene looping, affinity purification of TFIIB was performed in a looping 
deficient mutant strain of TFIIB called sua7-1. Affinity purified TFIIB preparation from 
sua7-1 cells was subjected to SDS-PAGE analysis followed by Western blotting using 
antibodies against Pap1 and CF1 subunit Rna15. Our results show that neither Pap1 
nor Rna15 were found associated with TFIIB in sua7-1 strain (Fig. 21, lane 2). Thus, 
TFIIB association with the terminator-bound factors occurred in a looping-dependent 
manner. These results argue in favor of a TFIIB-CF1-Pap1 complex playing a crucial 
role in loop formation. 
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II.3.6. GLYCEROL GRADIENT ANALYSIS OF HOLO-TFIIB COMPLEX 
 To further confirm that a holo-TFIIB complex exists in yeast cells, affinity purified 
TFIIB was subjected to sedimentation analysis on a linear 5-30% (v/v) glycerol gradient 
in the presence of 150 mM KCl. Western blot analysis revealed that TFIIB fractionated 
as a single peak spanning fractions 12 to 19 (Fig. 24). Pap1, as well as CF1 subunits: 
Rna14, Rna15, Pcf11, Hrp1, and Clp1, cosedimented with TFIIB (Fig. 24). The peak of 
CF1 subunits and Pap1 coincided with the TFIIB peak in fraction number 16 (Fig. 24). 
To conclusively prove that TFIIB cosedimenting with CF1 subunits and Pap1 is not free 
TFIIB, but TFIIB in a complex with 3’ end processing/termination factors, it was 
important to determine the sedimentation behavior of free TFIIB. For this, we purified 
recombinant TFIIB from bacteria and carried out sedimentation analysis under identical 
conditions. Recombinant TFIIB sedimented in fractions 19 to 22 with the peak centered 
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on fraction number 20 (Fig. 25). These results suggest that almost all TFIIB in the 
affinity purified preparation is in complex with 3’ end processing/termination factors. 
 However, when sedimentation analysis of affinity purified TFIIB was carried out in 
the gradient made in 500 mM KCl, TFIIB was separated from CF1 complex and 
sedimented at a lower rate in fractions 18 to 22 with the peak in fraction number 20 (Fig. 
25). To further corroborate the position of free TFIIB in the glycerol gradient, 
sedimentation analysis of affinity purified TFIIB was also performed in a gradient which 
contained 0.1% SDS. TFIIB and two subunits of CF1 (Rna14 and Rna15) were all found 
in higher peak fractions near 19-20 (Fig. 26). These results correlate with the position of 
free TFIIB based on the recombinant TFIIB peak centered on fraction 20. Thus, holo-
TFIIB complex is not stable upon prolonged exposure to high salt in a centrifugal field, 
though it is able to withstand high ionic strength for a short period of time during affinity 
purification. 
53 
 
 
 
We then compared the sedimentation profiles of the holo-TFIIB complex with the 
sedimentation profiles of RNAP II, TFIID and TFIIH complexes. The affinity purified 
TFIIB, RNAP II, TFIID and TFIIH were subjected to sedimentation analysis under 
identical conditions (Fig. 27). The presence of RNAP II, TFIID and TFIIH in the gradient 
fractions was detected by Western blot analysis using antibodies against the Rpb1, TBP 
and Kin28 subunits of RNAP II, TFIID and TFIIH respectively. RNAP II sedimented in 
fractions 3 to 8 with the peak in fraction number 6 (Fig. 27). TFIID, which has a 
molecular weight of about 750 kDa (23), sedimented in fractions 7 to 15 with the peak in 
fraction number 11 (Fig. 27), while TFIIH with an approximate molecular weight of  500 
kDa (80) sedimented in fractions 13 to 20 (Fig. 27). Thus, the sedimentation coefficient 
of the holo-TFIIB complex is intermediate between that of the TFIID and TFIIH 
complexes. We also looked for the presence of TFIIB in the gradient purified TFIID and 
TFIIH preparations. No signal for TFIIB was detected in the TFIID, TFIIH or RNAP II 
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glycerol gradient fractions (Fig. 27). This corroborated our earlier results that TFIIB is 
not in a complex with general transcription factors. 
II.3.7. SIZING COLUMN CHROMATOGRAPHY OF THE HOLO-TFIIB COMPLEX 
  Sedimentation analysis cannot provide accurate information about the size of 
the complex because it measures the relative buoyancy in the gradient. In order to find 
out the size of the holo-TFIIB complex, size exclusion chromatography was performed 
using the HA-affinity purified TFIIB preparation on a superdex-200 column. The column 
was calibrated with known sizing column markers. Elution profiles for each size marker 
ranging in size from 669 kDa (Thyroglobin) to 158 kDa (Aldolase) was monitored for UV 
absorbance and plotted (Fig 28). The superdex-200 column can accurately determine 
the molecular sizes above 660 kDa. The elution profile of the affinity-purified TFIIB was 
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monitored by UV as well as western blotting to confirm the presence of TFIIB with CF1 
subunits indicating the holo-TFIIB complex was still intact after sizing column 
chromatography (Fig 29). The peak fraction centered around an elution volume of 45 
ml, which was near the 2 MDa blue dextran elution volume, indicating that the holo-
TFIIB complex is less than 2 MDa (Fig 30). However, we could not accurately determine 
the size of holo-TFIIB complex from this column. 
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II.3.8. TFIIB AFFINITY PURIFICATION SPECIFICALLY ENRICHES FOR TFIIB IN A 
HOLO-TFIIB COMPLEX 
 Interestingly, there was no detectable signal for free TFIIB in either the glycerol 
gradient  or the sizing column fractions. One possibility is that most of the TFIIB inside 
the cell is present in the holo-TFIIB complex. In order to address this issue, size 
exclusion chromatography was performed using a whole cell extract prepared from a 
strain that harbored the HA-tagged TFIIB. The purified fractions were then examined by 
Western blotting for TFIIB. A similar peak for the holo-TFIIB complex was observed 
around the elution volume of 45 ml along with three additional peaks near elution 
volumes of 52, 59 and 68 ml (Fig 31). A reasonable estimate based on the blotting 
intensities, would be that approximately 25-30% of the TFIIB in the cell forms a holo-
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TFIIB complex. One possible explanation for this selective enrichment during affinity 
purification could be due to the two different conformations of TFIIB. In the closed 
conformation, the N terminus and C terminus interact in a manner similar to a closed 
wallet which could obfuscate the HA tag on the C-terminus. In order for TFIIB to interact 
with activators and RNAP II, it switches to an open conformation where the N- and C-
terminus are separated and free to physically interact with other proteins. TAP analysis 
of TFIIB were also attempted in an effort to increase the yield over the oligopeptide 
elutions. However, the addition of a TAP-tag to the C-terminal of TFIIB disrupted its 
physical interaction with the CF1 subunits, and this strategy wasn’t pursued further. 
II.3.9. KINETICS OF ACTIVATED TRANSCRIPTION IS COMPROMISED IN THE 
ABSENCE OF GENE LOOPING 
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  We have earlier demonstrated that gene looping is conferred by the activator-
dependent interaction of the promoter-bound proteins with the terminator-bound factors 
(83). Here we provide evidence for the existence of a complex of promoter-bound TFIIB 
with the terminator-associated factors in yeast cells. This complex could be the 
molecular basis of gene looping as it exists only in the looping competent strains, but 
not in the looping defective strain. Gene looping has been proposed to enhance 
transcription efficiency of a gene by coupling termination to reinitiation (235).  
In such a scenario, efficiency of transcription is expected to decrease in the 
absence of gene looping. We therefore compared kinetics of activated transcription of 
MET16 and INO1 in wild type cells that harbor holo-TFIIB complex and in the looping 
defective sua7-1 strain. Our results suggest that although both MET16 and INO1 
exhibited induced transcription in sua7-1 strain, activated transcription exhibited a 
kinetic lag in the looping defective strain (Fig. 32). The level of MET16 RNA in sua7-1 
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cells was about 1.5 times less than in isogenic wild type strain following 90 min after 
transfer of cells to inducing conditions (Fig. 32, lanes 3 and 6; Fig. 7C). Similarly, INO1 
RNA level in sua7-1 cells was approximately 2.5 times less than in wild type cells at 120 
min after induction of transcription (Fig. 32, lanes 3 and 6; Fig. 7F). A possible 
interpretation of these results is that a looped conformation helps a gene to achieve 
higher transcription efficiency within a short period of time following exposure of the 
cells to induction signal. 
II.4. DISCUSSION 
In this study, we have analyzed gene looping during transcriptional activation of 
protein encoding genes in budding yeast. Our results show that gene specific activators 
physically interact with TFIIB in a transcription dependent manner. An activator may 
function in association with TFIIB to keep a gene in the activated state through multiple 
rounds of transcription by facilitating reinitiation through gene looping. TFIIB plays a 
crucial role in gene looping. It has been proposed that the presence of TFIIB at the 
distal ends of a gene and a simultaneous absence of TBP from the terminator region 
are strong indicators of gene looping (83, 270). Our results with MET16 and INO1 
corroborate this view. The first round of transcription requires the recruitment of all 
general transcription factors and RNAP II on the promoter to form a PIC. Following 
initiation of transcription, most of the general transcription factors are left behind on the 
promoter in the form of a scaffold (325). During scaffold-based reinitiation, very few 
components have to be recruited back to the promoter to form a preinitiation complex. 
Reinitiation is therefore faster than initiation at least under in vitro conditions (143). If 
RNAP II is transferred directly from the terminator to the scaffold, the rate of reinitiation 
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is expected to be augmented even further (74). A gene looping assisted transfer of 
polymerase from the terminator to the promoter, with a concomitant increase in 
transcription efficiency, has been demonstrated during mitochondrial transcription (208). 
Here we demonstrate that there is a kinetic lag in the looping defective TFIIB mutant, 
which strongly suggests that RNAP II transfer from the terminator may be leading to 
higher rates of reinitiation. Other work from our lab, which further corroborates this 
hypothesis, has shown that in the termination defective mutants, gene looping is 
abrogated and results in a 2 fold decrease of RNAP II recruitment on the promoter (6). 
The localization of TFIIB on the terminator during active transcription and its 
genetic interaction with Ssu72 indicate that TFIIB could physically interact with the 
termination factors to mediate the formation of a gene looping complex. The results 
presented here show that TFIIB associates with the CF1 3’ end processing complex and 
Pap1 in yeast cells. We provide several lines of evidence in support of the existence of 
a complex of TFIIB and termination factors. First, cross-linking of TFIIB to the 3’ end of 
the gene, which is essential for loop formation, was abolished in looping-defective 
temperature-sensitive mutants of Pap1 and the CF1 subunits Rna14 and Pcf11 at non-
permissive temperatures. Second, affinity purification of HA-tagged TFIIB yielded a 
complex composed of Pap1 as well as CF1 subunits Rna14, Rna15, Pcf11, Clp1, and 
Hrp1. Third, a holo-TFIIB complex is devoid of known TFIIB interacting proteins such as 
RNAP II and TFIID. Thus, a TFIIB complex is not formed by transiently interacting 
proteins. Fourth, a glycerol gradient sedimentation profile of affinity-purified TFIIB 
showed a TFIIB peak cosedimenting with CF1 subunits and Pap1. Fifth, the 
sedimentation rate of affinity purified TFIIB is more than that of free TFIIB, thereby 
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suggesting that it is in a complex. These results provide strong support in favor of the 
existence of a macromolecular complex composed of TFIIB and 3’ end processing 
factors in yeast cells (Figure 33). 
Our results indicate that the association of TFIIB with Pap1 and the CF1 complex 
occurs only when the conditions are favorable for gene looping. First, Pap1 and CF1 
subunit, Rna15, associate with TFIIB in a looping-competent strain. No such association 
was observed in looping-deficient sua7-1 strain. Second, other work from our lab 
demonstrated CF1 subunits and Pap1 were found localized to the 5’ end of a gene only 
when it was in a looped conformation (212). These results suggest that a complex of 
TFIIB, Pap1, and CF1 is formed at the promoter-terminator junction to facilitate loop 
formation.  
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We expected at least two populations of TFIIB in a cell: 1) free TFIIB that is not 
engaged in transcription; 2) TFIIB in association with the terminator-bound factors on 
genes that are in looped configuration. Contrary to our expectation, we did not find any 
low sedimentation coefficient peak of free TFIIB in the glycerol gradient nor was there 
any indication of free TFIIB in the fractions collected from the sizing column. One 
possible reason for this could be that our affinity purification step is selectively purifying 
the holo-TFIIB complex. Following the elution of TFIIB from affinity beads using 
oligopeptides, there was still a substantial amount of TFIIB bound to the beads that 
could be eluted with 0.5% SDS (data not presented). This tightly bound TFIIB could be 
free TFIIB that was not be eluted with the anti-HA oligopeptides. Accordingly, we 
demonstrated the presence of free TFIIB when the cell lysate was directly fractionated 
on the sizing column. The earlier attempt to purify native TFIIB from yeast did not 
observe a holo-TFIIB complex (288). A possible explanation for this is that the holo-
TFIIB complex is not stable upon prolonged exposure to high ionic strength. When we 
performed sedimentation analysis of affinity-purified TFIIB at 500 mM KCl, TFIIB 
dissociated from the complex and sedimented at the position of free TFIIB. During the 
purification of native TFIIB from budding yeast by Tschochner et al. (288), at several 
steps in the purification protocol, ionic strength equivalent to or higher than 500 mM 
potassium acetate was used. This may have resulted in separation of TFIIB from the 
termination factors, and consequently, a holo-TFIIB complex was not observed. The 
holo-TFIIB complex may also include factors other than CF1 subunits and Pap1. It is 
likely that some components of CPF complex are present in the TFIIB macromolecular 
assembly. Ssu72, which is a subunit of CPF complex, exhibits a genetic as well as a 
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physical interaction with TFIIB, and is a strong constituent candidate of the TFIIB 
complex (72, 125, 278, 317). The presence of Pab1, Pab1-binding protein Pan1, and 
CPF subunit Fip1 in the tandem affinity-purified preparation of TFIIB makes them likely 
components of the TFIIB complex as well. Also, the presence of some promoter-bound 
factors in the TFIIB preparation cannot be ruled out. 
A similar interaction of mammalian TFIIB with CPSF and CstF, which are 
homologues of yeast CPF and CF1 cleavage and polyadenylation complexes, has also 
been observed (296). TFIIB exhibited a physical interaction with CstF-64 and mSsu72 
subunits of CstF and CPSF complexes, respectively. CstF-64 and mSsu72 were also 
found cross-linked to the distal ends of a gene in a manner analogous to their yeast 
counterparts. Furthermore, TFIIB  phosphorylation was required for the recruitment of 
CstF-64 and mSsu72 to the promoter region of a gene. Whether association of TFIIB 
with CstF and CPSF complexes facilitates juxtaposition of the promoter and terminator 
regions to form a gene loop in higher eukaryotes remains to be elucidated.  
TFIIB is absolutely required for initiation of transcription and its interactions with 
promoter-bound factors are well established. The essential role of TFIIB in gene 
looping, its interaction with the terminator-bound factors, and the kinetic delay in 
induced transcription suggests a novel role of TFIIB in looping-mediated transcriptional 
regulation. A genomewide search found TFIIB occupying both the promoter and the 
terminator regions of at least 120 genes in yeast (209). These results suggest that gene 
looping could be a general feature of transcriptionally activated genes in budding yeast. 
The role of gene looping may not be restricted to activation of transcription. We expect 
promoter-terminator interaction to have a wider implication in eukaryotic transcription. It 
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has been recently demonstrated that gene looping juxtaposes an inhibitory regulatory 
element located at the 3’ end of BRCA1 gene near its promoter region, leading to 
transcriptional repression of the gene in breast tumor cell lines (282). In this case, gene 
looping represses rather than activates transcription. In human B- and T-lymphocytes, 
interaction of the promoter with the terminator region of CD68 had an effect on the 
splicing of its primary transcript (234). A role for gene looping in preventing transcription 
interference has also been proposed in budding yeast, where gene density is high with 
little intervening space between neighboring genes (235). Gene looping may have 
different consequences, but it is certainly emerging as a general, possibly ubiquitous, 
transcription regulatory mechanism among eukaryotes. 
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CHAPTER III 
A NOVEL ROLE OF TFIIH KINASE, KIN28, IN TERMINATION OF TRANSCRIPTION 
IN BUDDING YEAST 
III.1. ABSTRACT 
 TFIIH is a general transcription factor with two different enzymatic activities, a 
kinase and a helicase activity. The kinase activity resides in the Kin28 subunit of TFIIH. 
There are conflicting reports regarding the role of Kin28 kinase in transcription cycle. 
Using an analog-sensitive mutant of Kin28, here we show that the Kin28 kinase is 
required for optimal transcription of both inducible and non-inducible genes in budding 
yeast. Transcription run-on analysis confirmed that the Kin28 kinase dependent 
enhancement of transcript level was the consequence of a direct affect of the kinase on 
transcription rather than on RNA stability. More importantly, RNAP II reads through the 
termination signal into the downstream regions of genes during kinase inhibition, 
thereby indicating a termination defect. The recruitment of Rna15 and Ssu72 subunits of 
CF1 and CPF termination complexes respectively near the 3′ end of genes was 
adversely affected in the kinase mutant. Both Rna15 and Ssu72 coimmunoprecipitated 
with Kin28 thereby suggesting a physical interaction of the kinase with the CPF and 
CF1 termination complexes. ChIP analysis revealed Kin28 crosslinking to both the 5′ 
and the 3′ ends of transcriptionally active genes. The localization of Kin28 towards the 3′ 
end of genes and its interaction with Rna15 and Ssu72, however, was compromised in 
the kinase-defective mutant. These results strongly suggest a novel role of Kin28 kinase 
in termination of transcription. CCC analysis revealed that gene looping, which is the 
physical interaction of the promoter and terminator regions of a gene during 
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transcription, was severely compromised in the Kin28 kinase mutant. We propose that 
Kin28 kinase dependent gene looping could be playing a crucial role in TFIIH-mediated 
termination of transcription in budding yeast.   
III.2. INTRODUCTION 
 Although TFIIH is a general transcription factor, its fundamental role in cell is not 
limited to transcription. It has additional cellular functions in DNA repair, and cell cycle 
regulation (80). Mutations in TFIIH subunits Ssl2 and Rad3 (XPB and XPD in humans) 
adversely affect both transcription and DNA repair, and cause autosomal recessive 
disorders; xeroderma pigmentosum, Cockayne syndrome and trichothiodystrophy (61). 
These diseases are characterized by predisposition of the affected individuals to 
cancer, ageing, developmental and neurological defects. The multiplicity of functions 
has made TFIIH the focus of intense investigation.  
 TFIIH is a multisubunit factor with a molecular weight of more than 500 kDa. It 
has been remarkably conserved during evolution, and has essentially the same subunit 
structure in yeast and higher eukaryotes (20, 99). The holo-TFIIH complex is composed 
of 11 subunits organized into two subcomplexes (Fig. 13) (224). The subunit 
organization of TFIIH reflects its multiplicity of functions in the cell. The core 
subcomplex comprising of Tfb1, Tfb2, Ssl1, Tfb4, Tfb5 and Rad3 in budding yeast, is 
required for transcription as well as DNA repair (99). Another subunit Ssl2 is loosely 
associated with the core subcomplex, and is indispensable for both transcription and 
repair of damaged DNA (224). Recently, an additional subunit Tfb6 was identified that 
facilitates dissociation of Ssl2 from the core subcomplex following the initiation of 
transcription (224). The kinase subcomplex, also known as TFIIK, is composed of Tfb3, 
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the cyclin Ccl1, and the cyclin-dependent kinase Kin28 (93). TFIIK phosphorylates the 
carboxy-terminal domain (CTD) of RNAP II at serine-5 and serine-7 residues, and is 
required for transcription as well as cell cycle control (3, 156). The structural analysis 
revealed TFIIH as an open ring like structure with a hole in the center that contacts 
DNA. The three-dimensional reconstruction of TFIIH on the basis of electron 
microscopy and X-ray diffraction studies places critical catalytic subunits of TFIIH in 
proximity of their target substrates (46). Ssl2 helicase crosslinked to DNA about 30 bp 
downstream of the transcription start site, while Kin28 kinase was found positioned near 
its CTD substrate. Rad3 helicase was localized near the DNA upstream of the 
transcription initiation bubble (126). 
 TFIIH is the only GTF with two distinct enzymatic activities: the DNA-dependent 
helicase activity and the cyclin-dependent kinase activity (80, 99). The helicase activity 
resides in two subunits, Ssl2 and Rad3, while Kin28 is the cyclin-dependent kinase. 
Ssl2 contacts template downstream of the transcription start site, and act as a molecular 
wrench to unwind DNA beyond the transcription bubble (126). This causes collapse of 
the initiation bubble, and facilitates release of the polymerase from the promoter for 
elongation, a step often referred to as the promoter clearance (199). Kin28 kinase 
phosphorylates serine-5 of CTD in the initiation complex (35, 159). The CTD-serine-5 
phosphorylation is believed to disrupt the interaction of the polymerase with the 
components of the initiation complex, thereby helping further in the promoter clearance 
(4, 196, 279, 308). The serine-5 phosphorylation also facilitates recruitment of the 
capping enzyme for 5ʹ end processing of nascent mRNA (93, 251). Kin28 was recently 
found to additionaly phosphorylates serine-7 of CTD (3, 79, 156).  
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 There are contradictory reports regarding the role of TFIIH kinase, Kin28, in 
transcription by RNAP II (20, 136, 147, 196). Transcription starts with the formation of 
PIC at the promoter. During PIC assembly, recruitment of GTFs and polymerase takes 
place in an ordered fashion, starting with TFIID followed by TFIIA, TFIIB, RNAP II-TFIIF, 
TFIIE and TFIIH in that order (Fig. 3) (111, 126, 248, 269, 285). RNAP II is recruited in a 
completely dephosphorylated form. The phosphorylation of CTD is not required either 
for PIC assembly or initiation of transcription (5, 35). The polymerase initiates 
transcription while sitting on the promoter, and still in contact with the general 
transcription factors (36, 164). The phosphorylation of serine-5 of CTD takes place 
immediately after initiation (159). The role of serine-5 phosphorylation has been found 
crucial for promoter clearance, which is the release of polymerase from the initiation 
complex for elongation (35, 142, 202, 308). The significance of serine-5 phosphorylation 
in the recruitment of capping enzyme for 5ʹ end processing of mRNA has been 
unequivocally demonstrated (53, 89, 211, 251). Our initial understanding of the function 
of TFIIH kinase under physiological conditions has come from studies with the 
temperature-sensitive mutants of Kin28 in budding yeast. Kin28 is an essential gene in 
yeast, as the cells lacking Kin28 are not viable. The shifting of Kin28 mutants to the 
elevated temperature adversely affected the recruitment of TFIIH complex at the 
promoter resulting in a dramatic decrease in the CTD-serine-5 phosphorylation, and a 
concomitant decrease in the level of steady state mRNA level in the cells (134, 196). 
The temperature-sensitive mutation has been found to affect the catalytic activity of 
Kin28 kinase as well as its interaction with other subunits of TFIIH (144, 151). To 
determine the specific role of Kin28 kinase in transcription by RNAP II, the ATP-binding 
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pocket of the enzyme was engineered to make it respond to a specific inhibitor NA-PP1, 
which is an analog of ATP. In the presence of NA-PP1, the kinase activity of analog-
sensitive Kin28 mutant (Kin28-as) is almost completely inhibited without affecting its 
interaction with the subunits of TFIIH complex (196). The studies using Kin28-as mutant 
revealed that the kinase activity is not required for recruitment of TFIIH at the promoter 
region. The startling finding was that Kin28 kinase is not essential for transcription (136, 
147, 308). A drastic decline in global transcript level in the absence of Kin28 kinase 
activity, however, was observed (136). This decrease in mRNA level in the Kin28-as 
mutant was attributed to the effect of serine-5 phosphorylation on capping of mRNA at 
the 5′ end rather than a direct role of Kin28 kinase in transcription (136). This view has 
been challenged by recent studies, which have reaffirmed the role of Kin28 kinase in 
promoter clearance (142, 308). These studies also implicated serine-5 phosphorylation 
in release of Mediator complex from the promoter-proximal region following initiation of 
transcription. Thus, the role of Kin28 kinase in transcription cycle remains elusive.   
 To investigate the precise role of Kin28 kinase in transcription by RNAP II, we 
examined the transcription of a number of inducible and constitutively expressed genes 
in Kin28-as mutant in the presence and absence of NA-PP1. Our results suggest that 
Kin28 kinase is not the absolute requirement for transcription, but is necessary for 
optimal transcription of both inducible and non-inducible genes. The kinase crosslinked 
to both the 5′ and 3′ ends of transcriptionally engaged genes. In the presence of analog 
NA-PP1, Kin28-as localization to the 5′ end of genes remained unaffected, but 
crosslinking to the 3′ end exhibited a dramatic decline. The delocalization of Kin28 from 
the 3′ end coincided with the polymerase reading through the termination signal. 
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Furthermore, gene looping was severely compromised in the kinase defective mutant. 
These results suggest a novel role of Kin28 kinase in termination of transcription, 
possibly through gene looping.   
III.3. RESULTS 
III.3.1. KIN28 KINASE IS REQUIRED FOR OPTIMAL TRANSCRIPTION OF BOTH 
INDUCIBLE AND CONSTITUTIVELY EXPRESSED GENES 
 The gene coding for Kin28 is essential for survival of yeast cells. Apart from the 
CTD-kinase activity, Kin28 is also essential for the recruitment of the holo-TFIIH 
complex at the promoter region of transcriptionally active genes. The CTD-kinase 
activity of Kin28 is neither essential for transcription nor for the survival of yeast cells 
(147). The growth of cells, however, is severely inhibited in the kinase-defective mutant, 
thereby suggesting that either Kin28 kinase is affecting the transcription cycle in a 
subtle way, or it is playing a role in a yet unknown aspect of cellular dynamic (Fig. 34) 
(147). To further probe the function of Kin28 kinase in transcription by RNAP II, we used 
an analog-sensitive strain of Kin28 called Kin28-as that has been used previously (196). 
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The Kin28-as strain is able to accommodate the analog NA-PP1. The analog is a highly 
specific competitive inhibitor of Kin28 kinase. In the presence of 5-10 µM NA-PP1 in the 
growth medium, the CTD kinase activity of Kin28-as mutant is almost completely 
inhibited within 60 minutes. 
 To investigate the precise function of Kin28 kinase in transcription cycle, we 
examined transcription of both inducible and constitutively expressed genes in Kin28-as 
mutant in the presence and absence of 7 µM NA-PP1 in the growth medium. Equal 
numbers of cells were harvested at 0, 30, 60 and 90 minutes following addition of NA-
PP1 to the cultures in mid-log phase. Total RNA was isolated and steady state level of 
mRNA was determined by RT-PCR approach. We first checked the effect of Kin28 
kinase on five inducible genes; HXT1, MET16, CHA1, GAL10 and INO1.  Our results 
show that a defect in Kin28 kinase affected the mRNA level of different inducible genes 
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to different extent. The transcript level of HXT1, MET16 and CHA1 decreased by about 
2-3 fold, of GAL10 by 5 fold, and of INO1 by about 10 fold in the Kin28-as strain in the 
presence of NA-PP1 (Fig. 35). No such decrease in RNA level was observed in the 
isogenic wild type strain in the presence of NA-PP1 or in the Kin28-as strain in the 
absence of NA-PP1 (Fig. 35). Next, we checked the role of Kin28 kinase on 
transcription of five constitutively expressed genes; ACT1, ASC1, MSN5, SPC2 and 
CMP2. A similar decline in mRNA level was observed for all five non-inducible genes 
tested in our experiments. The steady state amount of transcripts of ACT1, ASC1, 
MSN5, SPC2 and CMP2 registered a more or less uniform moderate decline of 2-3 
folds in the analog-sensitive mutant in the presence of NA-PP1 (Fig. 36). 
 The Kin28 kinase activity is essential for capping of mRNA at the 5′ end of genes. 
73 
 
 
 
Since capping of mRNA has been shown to affect the stability of mRNA, it was possible 
that the observed decrease in mRNA level of genes in the absence of kinase activity 
was not due to the effect of kinase on transcription, but on the stability of transcripts. To 
clarify the issue, we checked the nascent transcription of two inducible genes CHA1 and 
HXT1, as well as two constitutively expressed genes ACT1 and ASC1, by strand-
specific transcription run-on (TRO) approach. TRO assay is a better indicator of 
transcriptional activity of a gene than RNAP II density ChIP as it measures the position 
of transcriptionally active polymerase on a gene (Fig. 37). The Kin28-as cells were 
grown to the mid-log phase, and transcription was induced in the presence and absence 
of NA-PP1 as described previously. The strand- specific TRO analysis was carried out 
using Br-dUTP as described in Al Husini et al., (2013). The results show that the 
nascent transcription of CHA1 decreased by about 8 fold and of HXT1 by more than 20 
fold in the presence of NA-PP1 (Fig. 38). The nascent transcription of two constitutively 
expressed genes ACT1 and ASC1 also registered a steady 1.5-2 fold decline in the 
absence of Kin28 kinase activity (Fig. 38). 
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Thus, the decrease in the steady state mRNA level of both inducible and non-inducible 
genes observed by RT-PCR analysis was the consequence of a direct effect of kinase 
on transcription of genes. An additional indirect role of Kin28 kinase on stability of the 
transcripts has been shown, and cannot be ruled out here. 
III.3.2. KIN28 KINASE IS REQUIRED FOR TERMINATION OF TRANSCRIPTION 
 The strand-specific TRO analysis of genes in the Kin28-as strain revealed a 
startling rather unexpected role of Kin28 in RNAP II transcription cycle. In all four genes 
that we tested, polymerase read through the termination signal in the absence of Kin28 
kinase activity thereby signifying a defect in termination of transcription of these genes 
(Fig. 38). The TRO assay detects the presence of transcriptionally active RNAP II on a 
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gene. When termination is efficient, the active polymerase is restricted between the 
promoter and terminator regions of a gene. In the termination-defective mutants, 
however, polymerase reads through the terminator signal into the downstream region of 
the gene. TRO analysis revealed a weak polymerase signal in the downstream regions 
2 and 3 of CHA1, HXT1, ACT1 and ASC1 in the mutant in the absence of NA-PP1 (Fig. 
38). In the presence of NA-PP1, however, TRO signal in the downstream regions 2 and 
3 of all four genes increased by about 2-10 fold (Fig. 38). Thus, RNAP II was not able to 
read 
the termination signal of CHA1, HXT1, ACT1 and ASC1 efficiently under kinase-
defective condition and continued transcribing the downstream regions. These results 
suggest a role for Kin28 kinase in termination of transcription. The RNAP II density ChIP 
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assay corroborated readthrough of polymerase beyond the termination signal under 
kinase defective condition (Fig. 39).  
 To further probe the role of Kin28 kinase in termination, we checked the 
recruitment of CF1 and CPF termination complexes, which are required for both 3’ end 
processing/termination near the terminator region of genes in the kinase defective 
mutant.  We expected that if Kin28 kinase activity is required for termination of 
transcription, the recruitment of either CF1 or CPF or both complexes will be adversely 
affected under kinase defective condition. Both CF1 and CPF complexes are composed 
of multiple subunits (205, 249). We used a ChIP approach to monitor the recruitment of 
CF1 complex towards the 3' end of CHA1, HXT1, ACT1 and ASC1 genes using its 
Rna15 subunit, while SSu72 subunit was used to detect the recruitment of CPF 
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complex in the mutant strain. ChIP analysis revealed that both Rna15 and Ssu72 
occupied the terminator region of all four genes in the mutant in the absence of NA-PP1 
(Figs. 40 and 41). In the presence of NAPP1, however, crosslinking of Rna15 to the 3' 
end decreased by about 50-80% (Fig. 40), while that of Ssu72 declined by more than 
75% (Fig. 41).  Thus, the recruitment of both the CF1 and the CPF complexes towards 
the terminator region of CHA1, HXT1, ACT1 and ASC1 was compromised under the 
condition of deficient Kin28 kinase activity. Taken together these results strongly 
suggest a novel role for Kin28 kinase in termination of transcription for at least a subset 
of genes in budding yeast. 
III.3.3. MECHANISM OF TERMINATION OF TRANSCRIPTION BY KIN28 
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 The termination of transcription by RNAP II is dependent on CTD-serine2 
phosphorylation and requires CF1 and CPF 3′ end processing/termination complexes in 
yeast (2, 17, 29, 35, 72, 189, 249). The serine-2 phosphorylation starts during early 
elongation, continues throughout the coding region and drops sharply after the poly(A) 
site (78, 159). The phosphorylation of CTD at serine-2 facilitates recruitment of CF1 and 
CPF complexes near the 3′ end of a gene, which then brings about termination of 
transcription (131, 249). So far, there is no report of CTD-serine-5 or CTD-serine-7 
playing any role in termination of transcription in yeast or higher eukaryotes.  
 The Kin28 kinase may affect termination indirectly by influencing CTD 
phosphorylation towards the 3' end of genes, or directly by interacting with the 
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termination factors and facilitating their recruitment near the terminator region. To test 
the first scenario, we checked CTD phosphorylation status in different regions of CHA1 
and ACT1 in the analog-sensitive Kin28 mutant in the presence and absence of NA-
PP1.  ChIP analysis revealed no change in the CTD-serine2 phosphorylation pattern 
near the 3′ end of any of the two genes in the presence of NA-PP1 (Fig. 42 and 43). We 
then examined the phosphorylation status of CTD-serine-5 and CTD-serine-7 near the 
3′ end of CHA1 and ACT1 in the mutant strain. Although phosphorylation of serine5 
near the promoter-proximal region is well established, there are conflicting reports 
regarding its phosphorylation near the 3′ end of genes (78, 286). A few recent studies 
demonstrated phosphorylation of serine-5 at the 3′ end in a subset of yeast genes (78, 
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286). Our results are in agreement with these reports. We found elevated levels of 
serine5 phosphorylation at the 3′ end of both CHA1 and ACT1 (Fig. 42 and 43). A 
similar elevated level of serine-7 phosphorylation was observed near the terminator 
region of both genes (Figs. 42 and 43). In the presence of NA-PP1, however, a 2-4 fold 
decrease in phosphorylation of both serine-5 as well as serine-7 was observed for two 
genes in the analog-sensitive mutant (Fig. 42 and 43). These results ruled out the 
possibility of Kin28 kinase playing an indirect role in termination of transcription by 
affecting CTD-serine-2 phosphorylation near the 3′ end of genes. Since inactivation of 
Kin28 kinase resulted in lowering of both CTD-serine-5 and serine-7 phosphorylation 
near the 3′ end of genes (Fig. 42 and 43), the possibility of serine-5 and serine-7 playing 
a role in termination of transcription cannot be ruled out. 
III.3.4. KIN28 PHYSICAL INTERACTION WITH RNA15 AND SSU72 IS DEPENDANT 
ON ITS KINASE ACTIVITY 
 To check the possibility of a direct role of Kin28 in termination of transcription, we 
examined its interaction with the CF1 and CPF complexes using coimmunoprecipitation 
approach. The strains were constructed with the TAP-tagged version of Kin28-as allele, 
and either Myc-tagged Rna15 or Myc-tagged Ssu72. Kin28 was immunoprecipitated 
using IgG-Sepharose beads, and the presence of either Rna15 or Ssu72 was detected 
in the immunoprecipitated fraction in the presence and absence of NA-PP1. Our results 
show that Kin28 interacts with both CF1 subunit Rna15 and CPF subunit Ssu72 in the 
absence of NA-PP1 (Fig. 44). In the presence of NA-PP1, however, Kin28 interaction 
with both RNA15 and Ssu72 was completely abolished (Fig. 44). These results show 
81 
 
 
 
that Kin28 interacts with both the CF1 and CPF complexes, and this interaction is 
completely dependent on its kinase activity. In order to rule out the possibility that this 
interaction is DNA dependent, an identical co-immunoprecipitation was performed with 
an additional MNase treatment prior to purification (Fig. 45). Whether Kin28-CF1 and 
Kin28-CPF interactions are 
facilitated by the Kin28-mediated 
phosphorylation of CTD or that of a 
subunit of CF1 or CPF complex 
needs further investigation. The 
possibility of Kin28 influencing 
termination both indirectly by affecting the CTD phosphorylation in the terminator region, 
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and directly by interacting with the termination factors near the 3′ of the gene also 
cannot be ruled out.  
III.3.5. TFIIH LOCALIZATION TO THE DISTAL ENDS OF GENES DURING 
TRANSCRIPTION REQUIRES ITS KINASE ACTIVITY 
 The experiments described above firmly established the role of Kin28 kinase in 
termination of transcription of at least a subset of yeast genes. In order to have an 
insight into the role of Kin28 kinase in termination of transcription, we checked if Kin28 
brings about termination by physically interacting with the 3′ end of genes and if the 
kinase activity is required for this interaction.  The chromatin immunoprecipitation (ChIP) 
was performed in a strain bearing TAP-tagged version of Kin28-as allele. ChIP was 
performed in cells growing in the presence and absence of NA-PP1. As expected, Kin28 
was recruited towards the 5' end of CHA1, HXT1, ACT1 and ASC1 in the absence of 
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NA-PP1 (Fig. 46). In the presence of NA-PP1, however, crosslinking of Kin28 to the 
promoter region of both inducible and non-inducible genes registered a 50-80% decline 
(Fig. 46). Interestingly, Kin28 was also found localized near the 3' end of all four genes 
tested here (Fig. 46). A genomewide analysis has also found Kin28 crosslinked to the 3' 
end of a number of transcriptionally active genes in yeast (248). It was, however, not 
clear from this study if the recruitment of Kin28 near the terminator region required its 
kinase activity. We therefore repeated the ChIP experiment in Kin28-as mutant in the 
presence of inhibitory analog. Our results show that the crosslinking of Kin28 towards 
the terminator region of both genes was significantly reduced in the absence of its 
kinase activity (Fig. 46). The Kin28 ChIP signal at the 3' end of CHA1 and ACT1 
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decreased by nearly 50%, while at HXT1 and ASC1 more than 75% decline was 
observed under kinase-defective condition (Fig. 46).  
 In order to distinguish if Kin28 is being recruited as part of the TFIIK submodule 
or the entire TFIIH, ChIP was performed in kinase sensitive strains harboring a C-
terminal TAP-tagged Ssl2 or Tfb4. In both cases, the recruitment profile on the promoter 
and terminator regions were very similar to that observed for Kin28 in the presence and 
absence of the NA-PP1 inhibitor (Fig. 47). The overall conclusion of these results is that 
TFIIH, and not just TFIIK, is recruited at the promoter as well as terminator regions of a 
gene during transcription, and the kinase activity is required for the optimal recruitment 
of TFIIH to a gene. 
III.3.6. KIN28 KINASE IS REQUIRED FOR GENE LOOPING 
 We have earlier demonstrated the role of Mediator complex in transcription 
termination (221). We showed that Mediator-facilitated termination of transcription was 
dependent on the gene assuming a looped conformation. We therefore asked if Kin28 
kinase-mediated termination of transcription is also dependent on gene looping. CCC 
analysis of CHA1, HXT1, ACT1 and ASC1 was carried out in Kin28-as cells in the 
presence and absence of kinase activity. We have previously used this approach to 
demonstrate looping of genes in a transcription-dependent manner (83). In CCC assay, 
the physical interaction of the promoter and terminator regions of a gene is converted 
into a PCR product obtained using primers flanking the promoter (P1 primer) and the 
terminator (T1) regions as shown in Fig. 10 (82). CCC analysis revealed that CHA1, 
HXT1, ACT1 and ASC1 assume a looped gene conformation during transcription in wild 
type cells as indicated by a strong P1T1 PCR signal for all four genes (Fig. 48). In the 
85 
 
 
 
Kin28-as mutant also, a strong P1T1 looping signal was observed during induced 
transcription of CHA1, HXT1, ACT1 and ASC1 in the absence of NA-PP1 (Fig. 48). In 
the presence of NA-PP1, however, the looped gene architecture of all four genes was 
almost completely abrogated as there was 3-40 folds decline in P1T1 PCR signal for 
different genes (Fig. 48). Thus, the kinase activity of Kin28 is essential for gene looping. 
Whether Kin28 kinase-mediated gene looping contributes to the termination of 
transcription, however, needs further investigation.  
III.4. DISCUSSION 
 Since its discovery, the function of CTD kinase activity of TFIIH in transcription 
has been the focus of intense scrutiny. Using the analog-sensitive mutant of Kin28, it 
has been demonstrated that Kin28 kinase is neither essential for transcription nor for 
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survival of yeast cells (136, 147). These studies measured transcription in terms of 
steady state mRNA level, which is dependent on transcription as well as RNA 
degradation. The observed decrease in global transcript level in the absence of Kin28 
kinase activity was attributed to its affect on RNA stability rather on transcription per se 
(136). We therefore measured nascent transcription of selected genes in the presence 
and absence of Kin28 kinase activity by a TRO assay. Our results suggest that Kin28 
kinase is not an absolute requirement for transcription, but is required for optimal 
transcription of genes. Kin28 kinase may not be essential for transcription of all protein-
coding genes. The prevailing view is that the general transcription factors TFIID, TFIIB, 
TFIIF, TFIIE and TFIIH are required for the transcription of a vast majority of RNAP II-
dependent genes (201, 223, 292). This may not be entirely true. A recent study 
revealed that the TFIIB is required for transcription of only a subset of genes in humans 
(98). We propose that the Kin28 kinase activity of TFIIH may also not be necessary for 
transcription of all RNAP II-transcribed genes. If the TFIIH-kinase is required for 
transcription of a subset of non-essential genes, the cell may still be viable in the 
absence of the kinase activity, but the cell fitness may be adversely affected. This may 
explain why a defect in Kin28 kinase does not affect the cell viability and global poly(A)-
mRNA level appreciably, but is still necessary for normal growth of yeast cells. 
 The Kin28 kinase occupies both the 5′ and the 3′ end of genes. Most studies 
have focused on the role of TFIIH kinase at the 5′ end of genes. We, however, were 
curious regarding a possible function of Kin28 kinase at the 3′ end of genes. Here we 
demonstrate a novel role of Kin28 kinase in termination of transcription. We provide 
several lines of evidence in support of our claim. First, localization of Kin28 at the 3′ end 
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of genes is dependent on the kinase activity of protein. Second, recruitment of CF1 and 
CPF termination complexes towards the terminator end of gene is compromised in the 
absence of kinase activity. Third, the interaction of Kin28 with the CF1 and CPF 
complexes is almost completely abolished in the Kin28 kinase-defective mutant. Fourth, 
RNAP II reads through the termination signal into the downstream region under the 
kinase-defective condition. TFIIH is not the only general transcription factor that has 
been implicated in termination of transcription. A similar termination function has been 
found for TFIIB as well. Just like Kin28, TFIIB crosslinks to the 3′ end of genes and 
facilitates recruitment of the termination factors there (212). The termination function of 
TFIIB has been remarkably conserved during evolution, as it has been observed in a 
wide range of organisms as yeast, mammals and flies (128, 222, 296). We recently 
demonstrated the role of another initiation factor, Mediator complex, in the termination 
of transcription (221, 222). The emerging view is that the initiation and termination 
factors do not have exclusive roles in the initiation and termination steps of transcription 
respectively. We have shown that at least some initiation factors participate in the 
termination of transcription, while additionally, some termination factors function in the 
initiation/reinitiation of transcription (6).  
 We have previously demonstrated that gene looping facilitates interaction of the 
promoter-bound factors with the 3′ end of genes, and of terminator-bound factors with 
the 5′ end of genes (6, 83, 212, 221). We hypothesize that it is gene looping that allows 
a transcription factor to function at both the ends of a gene. The termination function of 
TFIIB is completely dependent on its interaction with the 3′ end of a gene. We propose 
that Kin28 crosslinking to the 3′ end of a gene, and its consequent role in termination of 
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transcription is also dependent on gene looping. Accordingly, we show that there is no 
gene looping in the Kin28 kinase defective mutant. These results suggest that the Kin28 
kinase activity is essential for promoter-terminator interaction. Loss of gene looping in 
Kin28-kinase deficient mutant coincides with the loss of Kin28 from the 3′ end of genes, 
and a defect in termination of transcription. A role of gene looping in termination of 
transcription by TFIIB has already been demonstrated. The possibility of Kin28-kinase-
mediated gene looping contributing to its termination function, therefore, cannot be ruled 
out. 
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CHAPTER IV 
CONCLUSIONS 
IV. 1. SUMMARY 
 The physical and genetic interactions of the promoter and terminator bound 
factors were initially only a hint that the initation and termination steps in the 
transcription cycle are intimately linked. The results presented here demonstrate that 
initiation factors such as TFIIB and TFIIH are simultaneously present at both the 
promoter and terminator regions of a gene during active transcription. Other work from 
our lab has shown similar results with the ‘promoter bound’ Mediator complex and 
‘terminator bound’ CF1 complex. Work using temperature sensitive mutants has 
revealed that these reciprocal localizations at the distal ends of a gene depended on the 
presence of functional complexes. The hypothesis that the physical contact of these 
complexes is the molecular basis of gene looping is strongly supported by the isolation 
of a holo-TFIIB gene looping complex containing CF1 subunits and the CPF subunit 
Pap1. Perhaps the most suprising result was the failure to detect TFIIH (Kin28) as part 
of the holo-TFIIB complex considering it also genetically interacts with Ssu72 and 
localizes on the terminator. This might be explainable given that in vitro evidence shows 
the release of TFIIB from the inititation scaffold that is left behind after the first round of 
transcription, composed at least partially of TFIID, TFIIA, and TFIIH. In vivo, it appears 
that TFIIB remains on the promoter, probably through gene looping interactions with the 
termination factors. Although at this point, the involvement of other promoter bound 
factors such as Mediator, in stabilizing TFIIB on the promoter, can not be ruled out. 
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 TFIIH localization on the terminator region was interesting with regard to gene 
looping because of the kinase activity of subunit Kin28. Phosphorylation is perhaps the 
most well investigated post translational modification which can dictate an ‘on’ or ‘off’ 
state for many proteins. While TFIIH wasn’t detected in the holo-TFIIB gene looping 
complex, TFIIH could still be playing crucial roles in the formation of such a complex. 
The results presented here clearly show a role for TFIIH in the termination process. 
While in vitro studies have shown termination factor recruitment on a CTD peptide 
phosphorylated at serine-2, it is unclear how stable these complexes are in vivo. The 
CTD ChIP results hint that TFIIH could be indirectly affecting their stability based on 
phosphorylation of the CTD at serine-7. In addition, TFIIH could be playing a more 
direct role based on its physical interaction with termination factors and phosphorylating 
them in order to function properly. Although it is not definitively proven, TFIIH appears to 
be responsible for phosphorylating TFIIB at serine-65, which has been shown to be 
required for the recruitment of termination factors to the promoter and terminator (296). 
In addition, p53 has been shown to override a lack of TFIIB for the transcription of 
damage response genes and also recruit termination factors in a manner similar to 
TFIIB forming a gene loop (267). This indicates that there may be other mechanisms 
which can result in the formation of gene loops, and perhaps the only requirement for 
any promoter bound factor is that it also interacts with termination factors. This could 
possibly be tested by simply fusing an activator protein with one of the termination 
factors. Also, many viral activator proteins are thought to recruit TFIIB directly to 
promoters without the formation of a usual PIC, driving a ‘short circuit’ to transcription 
initiation and gene looping. Recently, it has been shown that in differentiated kidney 
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cells, TFIIB is not necessary for transcription of all genes as previously thought. It was 
however, required for expression of the herpes simplex virus-1 (98). In the future, a 
better understanding of how gene loops form could be important for disrupting viral 
transcription. 
IV. 2. FUTURE DIRECTIONS 
 My work presented here is far from a complete story, and seems to create more 
questions than it has answered. The TFIIB work begs to ask at least a few questions 
regarding the holo-TFIIB complex. How big is it really? What are all of the composing 
factors? What is TFIIB interacting with directly where a single amino acid change 
prevents the formation of a gene looping looping complex? Furthermore, while not 
shown here, why does a C terminal TAP tag on TFIIB interfere with isolating a gene 
looping complex, but doesn’t affect TFIIB localization on the terminator? 
 In order to determine how big it really is, a different column needs to be used. 
Then, large amounts of the holo-TFIIB complex could be purified and concentrated 
enough to get good mass spec data. The most interesting question is finding what 
directly interacts with TFIIB near the region containing the E62K that is critical for gene 
looping. I have begun the process of creating point mutants (2 so far) that are capable 
of incorporating a photo-crosslinkable amino acid (Bpa) at the site. The factor(s?) could 
then be discovered using a Western blot if they had an affinity tag. Otherwise, bands 
could be cut out of the gel where a crosslinked TFIIB was present and then subjected to 
mass spec to identify the interacting protein. 
 The work presented here on TFIIH opens up several lines of interesting research 
in order to understand how TFIIH is affecting termination and gene looping. Is TFIIH 
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phosphorylating termination factors directly? Is the kinase activity of TFIIH facilitating 
the recruitment at the promoter and terminator through the CTD?It is also possible that 
TFIIH could be working in a kinase cascade with other kinases involved in initiation and 
termination. 
 While a few of the targets of Kin28 kinase are known, it is not known if any of the 
termination factors are among them. If TFIIH is targeting termination factors this could 
explain the lack of recruitment during kinase inhibition due to the inability of that factor 
to stabilize the association of that termination complex. Alternatively, it could also be 
due to the inability to phosphorylate other promoter bound factors perhaps acting in a 
role similar to TFIIB, where TFIIB phosphorylation stabilizes CF1 recruitment by direct 
interaction with Rna15 (296). TFIID and SAGA are both relatively large complexes (over 
15 subunits) and a few Kin28 targets have been found within them. In order to 
investigate this in an unbiased manner, inititiation and termination complexes would 
need to be purified and subjected to 2-dimensional PAGE to compare the spots with/out 
kinase inhibition. Those spots would then have to be analyzed with mass spec in order 
to identify the target proteins. Furthermore, those factors identified would then need to 
be mutated at the appropriate phosphorylation sites to ascertain if they are involved in 
gene loop formation. 
 While genomewide studies have provided key insights into patterns of CTD 
phosphorylation, recent studies indicate that creating an average pattern may not be 
reflective for all genes (286). Understanding the exact nature of how CTD 
phosphorylation patterns affect the stability and recruitment of the termination 
machinery will require the creation of several specific CTD mutants where each 
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phosphorylation event can be examined independently and in conjuction with each 
other. More specifically, does Kin28 physically associate with termination factors 
because both are binding to the CTD in close proximity? Given that the length of the 
yeast CTD can wrap entirely around RNAP II, it is not known if the specific 
phosphorylation marks have to be within the same 11 residue functional unit. It is 
necessary to create mutants where only one of the serines can be phosphorylated in 
isolation from the others to rule out that the proximity of marks on the CTD is a 
stabilizing factor. 
IV. 3. SPECULATIONS 
 It is interesting to contemplate how gene loops are actually formed from the 
correct juxtaposition of a specific terminator with its own promoter. How does a 
terminator know which promoter to associate with? According to Peter Cook, RNAP II 
never really escapes the promoter in vivo and instead pulls the DNA through it as it 
transcribes (177). So, promoter DNA remains in contact with the PIC and so does the 
elongating polymerase as it progresses to the terminator. This implies that formation of 
a gene loop begins during the elongation step of transcription. Upon reaching the 
terminator, this would bring that region into juxtaposition with the promoter and a 
bonified gene loop could be stabilized during termination. Further rounds of reinitiation 
would then form ‘elongation loops’ within the promoter-termination gene loop. Perhaps 
the ‘background’ signal in CCC analysis within a gene reflects this concept, especially 
where it concerns the intron/exon borders which indicate there are regions within a gene 
that associate with the promoter and terminator regions during transcription (217). 
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 The role of TFIIH in gene looping can also be further highlighted with regard to its 
function in DNA repair. Work from other labs have shown that during transcription 
coupled DNA repair, the region of DNA being repaired is recruited to the nuclear pore. 
This recruitment also leads to the transcription of otherwise inactive genes during their 
repair. This coincides with work from the Proudfoot lab that demonstrated that gene 
loops are dependant on nuclear pore localization (283). Perhaps TFIIH is the key 
player, where once it is recruited to the promoter or a site of damage, this invokes a 
shuttle mechanism to the nuclear pore. Transcription could then stabilize the formation 
of an elongation loop inititating through TFIIB phosphorylation, which occurs 
immediately after CTD-serine-5 phosphorylation (297). This mechanism also implies the 
existence of various ‘short circuits’ to transcription initiation that can bypass the usual 
progression of PIC formation dictated by the mediator response to gene specific 
activators. 
 In support of this ‘short circuit’ hypothesis, is the phenomenon of intron mediated 
enhancement of transcription (IME). The insertion of an intron into a repressed gene 
causes it to switch to into a fully on state with regard to transcription. This could occur  
due to transcription initiating from the distal ends of a gene, which occurs during basal 
and anti-sense transcription. If RNAP II transcribes to the intron without being 
destabalized, this would recruit the splicing machinery, and then the gene switches to 
an ‘elongation loop’ mode that leads to gene loop formation and the full on state for that 
gene. This would also explain why IME functions based on the proximity of the intron to 
the distal ends of a gene. 
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APPENDIX A: EXPERIMENTAL PROCEDURES 
A.1.1 CELL CULTURE (RT-PCR, 3C, ChIP or TRO) 
 Cell cultures were began from fresh plates (less than 3 weeks) in 5ml tubes in 
either YP-dextrose or synthetic Ura- drop out media. Cultures were grown at 30 °C for 
6-7 hours until evening and diluted 1:100 into 100 ml flasks of similar media. 100 ml 
flasks were grown overnight and the optical density was measured the next morning on 
a spectrophotometer at wavelength 600 nm (OD600). If cultures were overgrown, OD600 
>0.6, cultures were diluted in similar media down to an OD600~0.3 and grown to an 
OD600~0.4 to 0.6 depending on the experiment and genes being examined. Cultures 
were then transferred to appropriate media for induction of 1-2 hours. For MET16, 
CHA1 or HXT1 cells were grown to an OD600~0.5 and induced for 1 hour unless 
specified for a time course. For INO1 and GAL10 cells were grown to an OD600~0.4 and 
induced for 2 hours unless specified for a time course. For induction using the kinase 
inhibitor NA-PP1, 6um final concentration in DMSO was used when the cells were 
transferred into induction media. For induction using strains that are temperature 
sensitive, cells were grown at the permissive temperature of 25 °C to an OD600~0.4 to 
0.6 and then transferred to the non-permissive temperature of 37 °C for 2 hours unless 
specified otherwise. After induction the cells were then processed accordingly for each 
experiment. 
A.1.2 CELL CULTURE (CO-IP, Glycerol Gradient, FPLC)   
 Cell cultures were began from fresh plates (less than 3 weeks) in 5 ml tubes in 
either YP-dextrose or synthetic Ura- drop out media. Cultures were grown 6-7 hours 
until evening and diluted 1:200 into 1L flasks of similar media. 1L flasks were grown 
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overnight and optical density was measured the next morning on a spectrophotometer 
at wavelength 600nm (OD600). If cultures were overgrown, OD600 >2.0, cultures were 
diluted in similar media down to an OD600~0.6 and grown to an OD600~1.2 to 1.5. If cells 
were being induced the cells were transferred at an OD600~1.0 into 1L flasks of 
appropriate media and allowed to grow for an additional 1-2 hours before being 
processed for the experiment. 
A.2 RT-PCR 
Cells were grown as above. Cell pellets were washed with 5 ml DEPC treated water. 
Cells were transferred to 1.5 ml lock top tubes using 500 l of Trizol. 250 l of acid 
washed glass beads were added and cells were lysed by vortexing for 30 mintues at 4 
°C. Tubes were then punctured using a 22 gauge needle and drained into 15 ml tubes 
by centrifugation for 2 minutes at 2k rpm at 4 °C. Lysate was transferred to a fresh 1.5 
ml eppendorf and 500 ul of Trizol was added and incubated for 5 minutes at 25 °C. 200 
l of chloroform was added and mixed by vortexing, then centrifuged for 15 minutes at 
14k at 25 °C. The supernatant was transferred to a another eppendorf and three RNA 
phenol chloroform extractions were performed. The RNA was precipitated by adding 0.1 
volume of LiCl and 2.5 volumes of 100% EtOH and centrifuging for 20 minutes at 14k at 
25 °C. The RNA pellet was resuspended in 51 l of DEPC treated water and the 
quantity was measured using a nanodrop. The RNA concentration was adjusted to 100 
ng/l. Mulv reverse transcriptase was used to make cDNA using oligo-dT and 18S 
cDNA primers. Reactions were incubated using a thermocycler for the extension and 
deactivation steps. A negative control without reverse transcriptase was performed to 
ensure no DNA contamination contributed to any RT- PCR signal. cDNA was diluted 
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prior to PCR amplification by the addition of 180 l of 1x TE. The gene specific PCR 
primers used are listed in appendix C. Each PCR was normalized against the 18S 
ribosomal RNA control. 
A.3 STANDARD REVERSE TRANSCRIPTION REACTIONS (RT-PCR or TRO) 
 Reverse transcription reactions were all performed using Mulv reverse 
transcriptase (NEB). 10 l of diluted RNA (as specified in either RT-PCR or TRO) was 
incubated with either 2 l of oligo dT (25 [pM]) or gene specific primer at 65 °C for 5 
minutes followed by 4 °C for at least 2 minutes. To each sample, 8 ul of a master mix (4 
l H20, 2 l of 10x Mulv buffer, 1 l of dNTPs (NEB), 1 l of Mulv RT enzyme) was 
added. Samples were then incubated in a thermocycler at 37 °C for 45 minutes followed 
by inactivation at 65 °C for 20 minutes and then held at 4 °C. cDNA for RT analysis was 
diluted with the addition of 180 l 1x TE and cDNA for TRO analysis was diluted °C with 
the addition of 80 l of 1x TE.  
A.4 STANDARD PCR REACTIONS (RT-PCR, 3C, ChIP or TRO) 
 All PCR reactions were performed using Taq polymerase (NEB).  Each PCR was 
performed as a 25 l reaction using 16.5 l water, 2.5 l of 10x Taq polymerase buffer 
(NEB), 0.5 l of dNTPs (NEB), 0.5 l of Taq polymerase enzyme (NEB), 2 l of a pre-
mixed primer pair (5 l of each primer from 250 [pM] stock and 190 l water) and 3 l of 
template (either DNA or cDNA). For a first round analysis, a 30 cycle reaction would be 
performed followed by gel electrophoresis. Based on the initial band strength 
determined using the Kodak 1D software, other reactions would be performed in order 
to get band strengths in the 3000 to 80000 linear range for quanfification. If one of the 
primer pairs was either extremely strong or weak, either a different pair was chosen or it 
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was run separately for the necessary cycles to adjust the intensity into same range with 
the rest. For input or 18S normalization controls 26-29 reaction cycles were used 
(usually on the lower end). For ChIP and RT PCR using gene specific primers 28-32 
reaction cycles were used. For TRO and CCC the signals were often hard to see and 
required 33 to 36 reaction cycles to amplify quantifiable bands using 6 l of template 
instead of the normal 3 l. Quantification of band signals was performed as described 
below. 
A.5 TRANSCRIPTION RUN-ON ASSAY (TRO)  
 Cells were grown as described above. The transcription run-on assay was 
performed as described in Al Husini et al., 2013. 50 ml of cells were harvested after 
induction at an OD600~0.8. The cell pellet was washed with 10 ml of ice cold TMN buffer 
(10 mM Tris-HCl pH 7.5, 5 mM MgCl2, 100 mM NaCl) and resuspended in 940 μl of 
DEPC (Diethylpyrocarbonate)-treated ice cold water. Cells were permeabilized by the 
addition of 60 l 10% sarkosyl and incubated in an ice pack for 25 minutes while 
nutating at 4 °C. Cells were pelleted again using low speed centrifugation 1.2g for 6 
minutes at 4 °C. In vivo transcription elongation was then performed by suspending the 
cells in 150 l of reaction buffer (50 mM Tris-HCl pH 7.5, 100 mM KCl, 10 mM MgCl2, 2 
mM DTT, 0.75mM ATP, CTP, GTP and Brd-UTP, with 5 l RNAse inhibitor cocktail 
NEB). To allow for proper elongation, the reactions were incubated at 30 °C for 5 
minutes. The elongation reaction was immediately stopped with the addition of 500ul of 
ice cold Trizol reagent (Sigma). Cells were then lysed with 250 l acid washed glass 
beads (Sigma) for 20 minutes using a vortex at 4 °C. The tubes were punctured using a 
22 gauge needle and drained into 15 ml tubes by spinning 2k rpm at 4 °C. The lysate 
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was transferred to a 1.5 ml eppendorf and 500 l of Trizol was added and incubated at 
25 °C for 5 minutes. 200ul of chloroform (Sigma) was added and the tubes were 
vortexed briefly and centrifuged for 20 minutes at 14k rpm at 25 °C. Approximately 700 
l of supernatant was transferred to another 1.5 ml eppendorf tube and 700 l of RNA 
phenol chloroform pH 4.2 was added and vortexed briefly. Tubes were then centrifuged 
for 15 minutes at 14k rpm at 25 °C. The RNA phenol chloroform extraction was 
repeated 2x more to purify the RNA. Total RNA was precipitated with 1/16th volume of 
5M NaCl and 2.5 volumes of 100% ethanol and incubated overnight at -20 °C. RNA was 
pelleted by centrifugation for 20 minutes at 13.2k at 4 °C. The RNA pellet was washed 
once with ice cold 70% EtOH and resuspended in 100 l of DEPC treated water.  
 A bed volume of 25 l Anti-BrdU conjugated agarose beads (Sigma) were 
washed 3x using 500 ul of binding buffer (0.25x SSPE buffer, 1mM EDTA, 0.05% 
Tween20, 37.5 mM NaCl). Beads were blocked using 500 l of blocking buffer (485 l 
binding buffer, 5 l of 10% polyvinylpyrolidone, 10 l of Ultrapure BSA, Sigma) by 
nutating for 1 hour at 4 °C. RNA was further purified using the Qiagen RNA Easy kit and 
eluted twice with 50 l of DEPC treated water. Beads were washed 2x using 500 l of 
binding buffer and then 400 l of binding buffer was added to the beads and placed on 
ice. The eluted RNA was incubated at 65 °C water bath for 5 minutes and immediately 
placed on ice for 2 minutes. The RNA was then added to the beads and bound by 
nutating for 2 hours at 4 °C. Beads were then washed sequenctially using  500 ul of 
binding buffer, 500 l of low salt buffer (0.2x SSPE, 1 mM EDTA, 0.05% Tween20) 500 
l of high salt buffer (0.25x SSPE, 1 mM EDTA, 0.05% tween20, 100 mM NaCl) and 
500 l of TET buffer (1x TE buffer, 0.05% tween20). RNA was eluted 2x with 150 l of 
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elution buffer (20 mM DTT, 150 mM NaCl, 50 mM Tris-HCl ph 7.5, 1 mM EDTA, 0.1% 
SDS) by incubating at 42 °C for 5 minutes followed by a final elution with 200 l of 
elution buffer at 42 °C for 5 minutes. To the 500 l of elution, 500 l of RNA 
phenolchloroform ph 4.2 was added and vortexed and then centrifuged for 15 minutes 
at 14k rpm at 25 °C. Supernatent was transferred to fresh 1.5 ml eppendorf and RNA 
was precipitated with 0.1 volume LiCl and 2.5  100% EtOH by centrifugation for 20 
minutes at 14k rpm at 25 °C. RNA was resuspended in 26 l of DEPC treated water and 
the quantity was measured using a nanodrop. RNA concentration was adjusted to 50 
ng/l or the lowest concentration in the set. cDNA was made using strand specific 
primers listed in appendix C.  The primers were designed to synthesize cDNA at a 
region just 3’ of the open reading frame, the region near the poly (A) signal, and two 
more regions over 100 bp downstream from the poly (A) signal. 
A.6. CHROMATIN IMMUNOPRECIPITATION (ChIP) 
 Cells were grown as described above. Cell cultures were crosslinked by adding 
1% formaldehyde and shaking for 20 minutes at 25 °C. Crosslinking was quenched by 
the addition of 125 mM Glycine and shaking for 5 minutes at 25 °C. The cells were 
transferred to 50 ml conical tubes and pelleted by centrifugation at 3k rpm for 5 minutes 
at 4 °C. Cell pellets were washed with 10 ml of ice cold cell wash buffer (1x TBS, 1% 
Triton X100). Cells were transferred to 1.5 ml lock top tubes with 500 l of FA lysis 
buffer (50 mM Hepes-KOH ph 7.9, 140 mM NaCl, 1 mM EDTA, 1% Triton X-100, 0.1% 
Na deoxycholate, 1 mM PMSF). 250 l of acid washed glass beads were added and the 
cells were lysed by vortexing for 30 minutes at 4 °C. The tubes were punctured with a 
22 gauge needle and drained into 15 ml tubes by centrifugation for 2 minutes at 2k rpm 
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at 4 °C. The lysate was transferred to a 1.5 ml eppendorf tube and centrifuged for 15 
minutes at 13.2k rpm at 4 °C. The pellet was washed with 500 l of FA lysis buffer and 
then transferred to a 15 ml tube with 4ml of FA lysis buffer. Sonication was performed 
with the Branson digital sonifier and a 2 mm probe. Lysates were sonicated while 
suspended in an ice water batch at 25% duty cycle using 20 second pulses followed by 
20 second rest, for a total sonication time of 12 minutes. Sonicated lysate was then 
transferred into 1.5 ml eppendorf tubes and centrifuged for 15 minutes at 13.2k at 4 °C. 
Chromatin supernatents were then pooled per sample and aliquoted into 400 l 
amounts to be used for Input or immunoprecipitation.  
 For ChIP experiments in strains harboring a C-terminal Myc tagged protein, anti-
Myc conjugated agarose beads (Sigma) were used. For ChIP experiments in strains 
harboring a C-terminal HA tagged protein, anti-HA conjugated agarose beads (Pierce) 
were used. For ChIP experiments in strains harboring a C-terminal TAP tagged protein, 
IgG conjugated agarose beads (GE healthcare) were used. For ChIP experiments 
involving the use of antibodies against a selected protein, protein-A conjugated agarose 
beads (Sigma) were used. For CTD ChIP experiments, the antibodies for Ser2, Ser5 
and Ser7 phosphorylation were 3E10, 3E8 and 4E12 respectively (Millipore). 800 l of 
chromatin was incubated for 4 hours using 5 ul (or 20 l for 4E12) of antibody with 
gentle shaking at 4 °C prior to incubation with the agarose beads. 
 A bed volume of 20 ul of beads was washed three times with 500 l of FA lysis 
buffer. 800 l of chromatin was added to the beads and incubated overnight with gentle 
shaking at 4 °C. Beads were then spun gently for one minute at 1.5k rpm at 25 °C. All of 
the subsequent washing steps were performed at 25 °C. Supernatent was removed and 
102 
 
 
 
the beads were washed 2x with 1 ml FA lysis buffer containing 0.1% SDS. The beads 
were then washed 2x with 1ml FA lysis buffer containing 500 mM NaCl and 0.1% SDS. 
The beads were then washed 2x with 1ml ChIP wash buffer (10 mM Tris-HCl pH 8.0, 
250 mM LiCl2, 0.5% Na deoxycholate, 1 mM EDTA, 0.5% tergitol, 0.1% SDS). The 
beads were then washed with 1 ml of 1x TE (10 mM Tris-HCl pH 7.5, 1 mM EDTA). 
Purified chromatin was eluted 2x with 200 ul of elution buffer (50 mM Tris-HCl pH 7.5, 
10 mM EDTA, 1% SDS) by incubating at 65 °C for 10 minutes.  
 Eluted samples and input were then treated with 10 g of RNAse A by incubation 
at 37 °C for 15 minutes. For input samples 0.1% SDS was added. Samples were 
treated with 20 g proteinase K at 42 °C for 90 minutes. Reversal of crosslinking was 
done by incubating samples at 65 °C for overnight (or 6 hours minimum). DNA was 
purified by performing 2x DNA phenol chloroform  pH 7.5 extractions. The DNA was 
precipitated by EtOH precipitation using 0.1 volume Na Acetate and 2.5 volumes EtOH 
and 2 l of glycogen as a carrier and also to aid in visualizing the pellet. For every batch 
of sonicated chromatin, one set of input was resuspended in 20 l of 1x TE and 3 l of 
10x loading dye to verify DNA fragment size was below 500 bp by gel electrophoresis. 
Input was resuspended in 101 l 1x TE and immunoprecipitated (IP) samples were 
resuspended in 51 l of 1x TE and the quantity was measured using a nanodrop. Inputs 
were routinely normalized to 100 ng/l and IP samples were normalized to 50 ng/ul or to 
the lowest concentration in the set of IP samples. The primers used for PCR analysis 
were chosen based on the region of a gene to detect and to be of similar sized 
amplicons when possible. The primers used for ChIP PCR analysis are in appendix C. 
A.7. CHROMOSOME CONFORMATION CAPTURE ANALYIS (3C) 
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 Cell cultures were grown as described above (A.1). Crosslinking was performed 
by the addition of 1% formaldehyde and incubation for 30 minutes at 25 °C with gentle 
shaking. Crosslinking was quenched by the addition of 125 mM Glycine and shaking for 
5 minutes at 25 °C. The cells were transferred  to 50 ml conical tubes and pelleted by 
centrifugation at 3k rpm for 5 minutes at 4 °C. Cell pellets were washed with 10 ml of ice 
cold cell wash buffer (1x TBS, 1% Triton X100).  Cells were then washed again with 10 
ml of ice cold 1x TBS). Cells were transferred to 1.5 ml lock top tubes with 500 ul of FA 
lysis buffer (50 mM Hepes-KOH ph 7.9, 140 mM NaCl, 1 mM EDTA, 1% Triton X-100, 
0.1% Na deoxycholate, 1 mM PMSF). 250 l of acid washed glass beads were added 
and the cells were lysed by vortexing for 30 minutes at 4 °C. The tubes were punctured 
with a 22 gauge needle and drained into 15 ml tubes by centrifugation for 2 minutes at 
2k rpm at 4 °C. The lysate was transferred to a 1.5 ml eppendorf tube and centrifuged 
for 15 minutes at 13.2k rpm at 4 °C. The pellet was resuspended in 1ml of ice cold FA 
lysis buffer with 0.1 % SDS and incubated at 4 °C with gentle shaking. Samples were 
then centrifuged for 15 minutes at 13.2k rpm at 4 °C and the pellet was resuspended in 
1 ml FA lysis buffer and incubated for 10 minutes at 4 °C with gentle shaking. Samples 
were then centrifuged for 15 minutes at 13.2k rpm at 4 °C and the pellet was 
resuspended in 1 ml of ice cold water and centrifuged again similarly. Washed pellets 
were then resuspended in 500 l of TM buffer (10 mM Tris-HCl pH 7.5, 5 mM MgCl2) 
and aliquotted in 45 l amounts in 1.5 ml flat eppendorf tubes. Samples were flash 
frozen in liquid nitrogen and stored at -80 °C until use.  
 5 l of 10% SDS was added to each 45 l sample and incubated for 30 minutes 
at 37 °C with gentle shaking, followed by the addition of 8 l of 10% Triton X-100 and 12 
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ul of water and another incubation for 30 minutes at 37 °C with gentle shaking. 10 l of 
10x restriction enzyme buffer (3.1 or cutsmart, NEB) and 10 l each of AluI and NlaIV 
(10 U/l, NEB) were added to each sample and incubated at 37 °C for 6 hours with 
gentle shaking. An overnight double digestion was then performed by the addition of 70 
l water, 10 l of 10x restriction enzyme buffer and another 10 l of each enzyme 
followed by an overnight incubation at 4 °C with gentle shaking.  
 The next morning inactivation was performed by the addition of 5 l of 10% SDS 
and incubation at 65 °C for 30 minutes. The SDS was then chelated by the addition of 
75 l of 10% Triton X-100 and 95 l of water followed by incubation for 30 minutes at 37 
°C with gentle shaking. Ligation was performed by the addition of 375 l of 2x Quick 
Ligation Buffer (NEB) and 5 l of Quick Ligase enzyme and incubation for 90 minutes at 
25 °C with gentle shaking. Proteins were then digested by the addition of 7.5 l of 10% 
SDS, 20 l of 5M NaCl and 5 l of 20 mg/ml proteinase K followed by incubation for 2 
hours at 42 °C. 10 l of additional proteinase K was then added to each sample and 
crosslinks were reversed by incubation overnight at 65 °C. The next morning DNA was 
purified by 3x DNA phenol chloroform pH 7.5 extractions. The supernatant was then 
transferred to a 2 ml microcentrifuge tube and the DNA was precipitated by EtOH 
precipitation using 0.1 volume 3 M Na acetate pH 5.2 and 2.5 volumes 100% EtOH and 
2 l of 20 mg/ml glycogen followed by centrifugation for 30 minutes at 14k rpm at 25 °C. 
The DNA pellet was then resuspended in 51 l of 1x TE and quantity measured on a 
nanodrop. The concentration was then adjusted to either 100 ng/l or the lowest 
concentration in the set of tubes. Gene specific primers were then chosen in order to 
identify promoter terminator interactions by a specific length ligation product. Control 
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primers spanning undigested regions were used to normalize 3C PCR signals against. 
The primers used for PCR analysis are listed in appendix C. 
A.8. CO-IMMUNOPRECIPITATION (CO-IP) 
 Cells were grown as described above (A.1.2). Each liter of culture was split into 2 
500 ml centrifuge tubes and centrifuged at 3k rpm for 5 minutes at 4 °C. The cell pellet 
obtained was washed once with 50 ml of ice-cold 1x TBS buffer containing 1% Triton X-
100 and centrifuged again. The cell pellet was then washed with 50 ml of ice cold water 
and transferred to 50 ml conical tubes and centrifuged at 3k rpm for 5 minutes at 4 °C. 
The pellet (usually close to 7 ml) was resuspended in 9 ml of IP lysis buffer (20 mM 
Tris-HCl pH 8.0, 150 mM KCl, 0.5 mM EDTA, 1 mM MgCl2 , 0.1% Triton X-100, and 1 
mM PMSF) and  flash frozen drop by drop using an automated pipet in liquid nitrogen. 
The frozen cell pellet was homogenized to a very fine powder using a liquid nitrogen 
chilled mortar and pestle, transferred to a beaker, and allowed to thaw slowly on ice. 
The resulting cell lysate was centrifuged at 16,400 rpm for 20 min in a Sorvall SS-34 
rotor, and the supernatant was transferred to a 15 ml tube. A 200 l aliquot was 
transferred to a 1.5 ml eppendorf and 50 ul of 5x laemmli buffer (50% glycerol, 25% 2-
mercaptoethanol, 10% SDS, 300 mM Tris-HCl pH 6.8, 0.01% bromophenol blue) was 
added to be used for input 
 For CO-IP experiments in strains harboring a C-terminal Myc tagged protein, 
anti-Myc conjugated agarose beads (Sigma) were used. For CO-IP experiments in 
strains harboring a C-terminal HA tagged protein, anti-HA conjugated agarose beads 
(Pierce) were used. For CO-IP experiments in strains harboring a C-terminal TAP 
tagged protein, IgG conjugated agarose beads (GE healthcare) were used. For CO-IP 
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experiments using anti-TFIIB antibodies, 50 l of antiserum was bound with lysate for 1 
hour at 4 °C with gentle agitation prior to incubation with protein A Sepharose beads 
(GE healthcare). A bed volume of 50 l of affinity beads was washed 3x with IP lysis 
buffer prior to binding. For the MNase controls, the cell lysate was incubated with 300 
units of MNase at 37 °C for 30 min prior to binding to the affinity beads. For the high salt 
controls, the IP lysis buffer was prepared as described above using a 500 mM KCl 
concentration. 
  Cell lysate was used to transfer the beads back into the 15 ml tube for binding. 
The binding was performed at 4 °C for 4 hours with gentle shaking. Following binding, 
the 15 ml tubes were centrifuged at 1k rpm for 2 minutes at 4 °C and another 200 ul 
aliquot was removed from the supernatant for flow through, the remaining supernatant 
was discarded. The beads were transferred to microcentrifuge tubes and washed five 
times with 1 ml each of IP wash buffer (20 mM Tris-HCl, pH 8.0, 50 mM KCl, 0.5 mM 
EDTA, 1 mM MgCl 2 , 1 mM PMSF, and 0.1% Triton X-100).  
 Elution was performed by one of three methods depending on the experiment 
and the affinity tag used for immunoprecipitation. For experiments that only required 
further SDS PAGE and Western blot analysis, elution was performed by using Laemmli 
buffer directly. For experiments that required further analysis by glycerol gradient 
sedimentation or FPLC analysis elution was performed with specific peptides for either 
cMyc or HA tags; or using proteolytic cleavage of the TAP tag. 
 For elution with Laemmli buffer, 200 l of water and 50 l of 5x Laemmli buffer 
was added to the beads. The samples were eluted by incubating for 15 minutes at 25 
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°C with gentle shaking. The samples were then centrifuged at 1.5k for 2 minutes at 25 
°C and the supernatents were transferred to1.5 ml eppendorf tubes. 
 For elution with HA or c-Myc oligopeptides (Genscript), 200 l of oligopeptide 
elution buffer (see below) was added to the beads and incubated for 30 minutes at 25 
°C with gentle shaking. Due to the different number of peptide repeats in each C-
terminal tag, 3x HA and 13x c-Myc, the concentrations for each oligopeptide were 
adjusted for elution. The HA-oligopeptide elution buffer used a concentration of 100 
mg/ml in IP lysis buffer, and the c-Myc oligopeptide elution buffer used a concentration 
of 500 mg/ml in IP lysis buffer. After elution, samples were centrifuged at 1.5k rpm for 2 
minutes at 25 °C and the supernatant was transferred to a 1.5 ml eppendorf tube and 
kept on ice to be used for either glycerol gradient sedimentation or FPLC analysis. 
 For elution against a TAP tagged protein using proteolytic cleavage, TurboTEV 
(MC Labs) was used against the TEV sequence in the TAP tag. The elution was 
performed by the addition of 195 l of IP lysis buffer (worked better than the supplied 
buffer) with 2 mM DTT and 5 l of TurboTEV enzyme followed by incubation either for 
60 minutes at 25 °C, or overnight at 4 °C. After elution, samples were centrifuged at 
1.5k rpm for 2 minutes at 25 °C and the supernatant was transferred to a 1.5 ml 
eppendorf tube and kept on ice for further use. 
A.9 SDS PAGE and WESTERN BLOTTING 
 Eluted samples containing 1x Laemmli buffer were first heated for 20 minutes at 
95 °C prior to loading. 10% gels were prepared using 1.5 mm premade cassettes 
(Invitrogen). The eluted proteins were separated by SDS-PAGE and transferred to a 
polyvinylidene difluoride (PVDF) membrane using an Amersham Biosciences TE70 
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semi-dry transfer apparatus. Following transfer, the membrane was additionally blocked 
by submerging in 100% methanol for a few seconds and then allowed to either dry 
overnight or in the 65 °C oven for 15 minutes. 14 ml of antibody solutions were prepared 
in 1x TBS with 0.25 g of nonfat dry milk according to manufacturer recommended 
dilutions for western blotting. For primary antibodies 140 l of 1% sodium azide was 
added as a preservative and primary solutions were used for up to 3 months. Blotting 
was performed by incubating the membrane protein side down in the antibody solution 
for 1-2 hours, followed by two 5 minute washes in 1x TBS with gentle shaking. The 
protein bands were visualized using the Pierce Pico chemiluminescent reagents. 
A.10 ACTIVATOR-TFIIB CO-IP 
 For coimmunoprecipitation using HA-tagged transcription activators, the cells 
were grown in 1 liter of appropriate medium to an A 600 of 1.0–1.2 and then induced for 
2 h. Cross-linking was performed by incubating the cells in formaldehyde (final 
concentration, 0.5%) for 20 min, and the reaction was stopped by the addition of glycine 
(final concentration, 125 mM ). The cell pellet was washed and lysed as described 
above. Cell lysate was subjected to sonication (30 pulses of 10s each at 25% duty cycle 
with 30s rest in between). The resulting cell lysate was centrifuged at 16,400 rpm for 20 
min in a Sorvall SS-34 rotor. The supernatant was used for immunoprecipitation. One 
sample of the cell lysate, grown under induced conditions, was pre-treated with 10 units 
of micrococcal nuclease (WorthingtonLabs) for 30 min at 37 °C prior to binding. A 1-ml 
aliquot of the micrococcal nuclease-treated cell lysate was checked for complete 
digestion of chromatin by running on 1.5% agarose gel following deproteinization and 
crosslinking removal of samples.  
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A.11. GLYCEROL GRADIENT SEDIMENTATION  
 Affinity-purified samples were pipette mixed with an equal volume of ice-cold IP 
lysis buffer without glycerol and incubated for 20 min on ice. For each sample 20 ml of 
IP lysis buffer with 5% glycerol and 30% glycerol were prepared. Gradient analysis was 
performed in Seton 25 mm x 89 mm polyallomer tubes by first layering 19.5 ml of IP 
lysis buffer with 5% glycerol on the bottom using a syringe. Then carefully adding to the 
bottom, 19.5 ml of IP lysis buffer with 30% glycerol using a syringe placed in the center 
of the tube. The gradient tubes were then mixed on a Biocomp gradient master to 
create linear gradients using the settings: Time 1:30 seconds, Angle 75 degrees and 
Speed 25. The purified samples were loaded on the top of the gradient by pipetting 
slowly and touching the drops to the surface.  The samples were then immediately 
centrifuged at 30,000 rpm for 18 h at 4 °C. Fractions of 1.8 ml each were collected 
manually using a Beckman fraction recovery system by puncturing the bottom, and 40 
ul of each fraction was used for SDS PAGE and Western blotting.  
A.12. FAST PRESSURE LIQUID CHROMATOGRAPHY (FPLC) 
 Affinity purified samples were combined from 4L of culture into a 1ml eppendorf 
tube. Sample was loaded into a 1 ml loop on the FPLC machine and a custom program 
was used to automate the collection of 1 ml fractions following passage of the void 
volume (39 ml). 54 fractions were collected after size exclusion chromatography using a 
superdex 200 column. Chromatography was performed using IP lysis buffer.   
A.13 YEAST STRAIN CREATION 
 All yeast strains were created following a Lithium acetate transformation protocol. 
Cells were grown to an OD600~0.6 and washed with 10 ml of ice cold Lithium acetate 
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buffer (100 mM LiOAc, 10 mM Tris-HCl pH 8.0, 1 mM EDTA). Cells were transferred 
with 100 l of ice cold Lithium acetate buffer into eppendorf tubes containing the 
construct DNA and gently shaken for 5 minutes at 25 °C. The construct DNA was 
created from PCR using the high fidelity advantage enzyme and gene specific primers 
coupled with a tag or knock out plasmid listed in appendix C. Cells were then incubated 
with 280 l of PEG solution (50% PEG 4000,100 mM LiOAc, 10 mM Tris-HCl pH 8.0 
and 1 mM EDTA) for 45 minutes at 25 °C.  Cells were then heat shocked with the 
addition of 43 l DMSO for 5 minutes at 42 °C and immediately transferred to ice for at 
least 2 minutes. Cells were then centrifuged at 4k rpm for 30 seconds at 25 °C and the 
pellet was washed with 500 l of either sterile water or media.  For transforms using 
kanamyacin, cells were allowed an outgrowth period of two hours in non-selective 
media prior to plating. Cells were then resuspended and plated on selective plates. 
Colonies were isolated and positive transformants were screened by gene specific 
primers to verify the strain. 
A.14 CLONING AND PURIFICATION OF RECOMBINANT TFIIB 
 The gene coding for yeast TFIIB, SUA7, was cloned into the NdeI-EcoRI sites of 
pET24a. Recombinant plasmid was transformed into the BL21 strain of Escherichia coli. 
Induction of recombinant TFIIB and preparation of cell lysate were performed as 
described by Ansari and Schwer (14). His-tagged TFIIB was affinity-purified on a Cobalt 
resin (Pierce Scientific) following the manufacturer’s guidelines. 
A.15. QUANTIFICATION 
 Initial quantification was performed using two independent replicas of each 
experiment followed by two rounds of PCR. For each PCR reaction, lanes were loaded 
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on duplicate gels in order to account for human pipetting error while loading. For each 
set of gels to be quantified following PCR, fresh agarose was prepared and all gels 
were poured at once in order to avoid differences in gel density when staining with 
ethidium bromide. Gels were stained for 20 minutes in a fresh solution of 200 ml 1x TAE 
with 10 ul of ethidium bromide (10 mg/ml). The signal strength of gel bands was 
analyzed using the Kodak Gel Logic 200 system after 2 second exposure. Pictures were 
analyzed using the Kodak 1D software to calculate the net intensity. The net intensities 
were then used to calculate a ratio of the signal of interest / control, and these ratios 
were averaged and the standard deviation was calculated. If standard deviations 
overlapped or displayed large variation, first another round of PCR and quantification 
was performed and averaged in. If there were still large standard deviations, a third 
replica experiment was performed and analyzed.  
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APPENDIX B: STRAINS 
B.1. STRAINS USED IN CHAPTER II 
Strain 
  
genotype Reference 
FY23 MATa ura3-52 trp163 leu21 Madison and Winston, 
1997 (1) 
SSR2 MATa ura3-52 trp163 leu21, MET28-
3xHA, KanMX 
 
Kaderi et al, 2009 
SAM6 MATa ura3-52 trp1Δ63 leu2Δ1, 
Δmet28::KanMX 
 
Kaderi et al, 2009 
BY4733 MATa his3200 trp163 leu20 
met150 ura30 
 
Hampsey lab 
SRR3 MATa his3Δ200 trp1Δ63 leu2Δ0 
met15Δ0 ura3Δ0, INO2-3xHA, KanMX 
 
Kaderi et al, 2009 
BEK3 MATa his3Δ200 trp1Δ63 leu2Δ0 
met15Δ0 ura3Δ0 Δino2::KMX 
 
Kaderi et al, 2009 
YMH867 MATa leu2-3 can1-100 ura3-1 ade2-1 
his3-11,15 trp1-1 GAL1 promoter 
upstream of BUD3, HIS3+ 
 
Ansari and Hampsey, 
2005 (2) 
SRR4 MATa leu2-3 can1-100 ura3-1 ade2-1 
his3-11,15 trp1-1, Gal1p-BUD3, HIS+, 
GAL4-3xHA, KanMX 
 
Kaderi at al, 2009 
SAM4 MATa leu2-3 can1-100 ura3-1 ade2-1 
his3-11,15 trp1-1,Gal1p:BUD3, HIS+, 
Δgal4::KMX 
 
Kaderi at al, 2009 
SRR1 MATa leu2-3 can1-100 ura3-1 ade2-1 
his3-11,15 trp1-1,Gal1p-BUD3, HIS+, 
RNA15-TAP,TRP+ 
 
Kaderi at al, 2009 
AA1 MATα ura3-1 trp1-1 ade2-1 leu2-3,112 
his3-11,15 rna14-1 SUA7-TAP, TRP+ 
 
Medler et al, 2011 
AA2 MATa ade1/ade2 lys2 ura3-52 pap1-1 
SUA7-TAP, TRP+ 
 
Medler et al, 2011 
SRR7 MATa his3Δ200 trp1Δ63 leu2Δ0 
met15Δ0 ura3Δ0 
RNA14-TAP, URA+ 
 
Medler et al, 2011 
SRR8 MATa his3Δ200 trp1Δ63 leu2Δ0 
met15Δ0 ura3Δ0 
PCF11-TAP, URA+ 
 
Medler et al, 2011 
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SAM50 MATa his3Δ200 trp1Δ63 leu2Δ0 
met15Δ0 ura3Δ0, RNA14-13xMyc, TRP+ 
 
Medler et al, 2011 
SAM51 MATa his3Δ200 trp1Δ63 leu2Δ0 
met15Δ0 ura3Δ0, RNA15-13xMyc, TRP+ 
 
Medler et al, 2011 
SAM52 MATa his3Δ200 trp1Δ63 leu2Δ0 
met15Δ0 ura3Δ0, PCF11-13xMyc ,TRP+ 
 
Medler et al, 2011 
SAM53 MATa his3Δ200 trp1Δ63 leu2Δ0 
met15Δ0 ura3Δ0, CLP1-13xMyc, TRP+ 
 
Medler et al, 2011 
SAM54 MATa his3Δ200 trp1Δ63 leu2Δ0 
met15Δ0 ura3Δ0, HRP1-13xMyc, TRP+ 
 
Medler et al, 2011 
SAM55 MATa his3Δ200 trp1Δ63 leu2Δ0 
met15Δ0 ura3Δ0, PAP1-13xMyc, TRP+ 
 
Medler et al, 2011 
SAM56 MATa his3Δ200 trp1Δ63 leu2Δ0 
met15Δ0 ura3Δ0, SUA7-3xHA, HIS+ 
 
Medler et al, 2011 
SAM58 MATa his3Δ200 trp1Δ63 leu2Δ0 
met15Δ0 ura3Δ0, SUA7-3xHA, HIS+, 
RNA14-13xMyc, TRP+ 
 
Medler et al, 2011 
SAM59 MATa his3Δ200 trp1Δ63 leu2Δ0 
met15Δ0 ura3Δ0, SUA7-3xHA, HIS+, 
RNA15-13xMyc, TRP+ 
 
Medler et al, 2011 
SAM60 MATa his3Δ200 trp1Δ63 leu2Δ0 
met15Δ0 ura3Δ0, SUA7-3xHA, HIS+, 
PCF11-13xMyc ,TRP+ 
 
Medler et al, 2011 
SAM61 MATa his3Δ200 trp1Δ63 leu2Δ0 
met15Δ0 ura3Δ0, SUA7-3xHA, HIS+, 
CLP1-13xMyc, TRP+ 
 
Medler et al, 2011 
SAM62 MATa his3Δ200 trp1Δ63 leu2Δ0 
met15Δ0 ura3Δ0, SUA7-3xHA, HIS+, 
HRP1-13xMyc, TRP+ 
 
Medler et al, 2011 
SAM63 MATa his3Δ200 trp1Δ63 leu2Δ0 
met15Δ0 ura3Δ0, SUA7-3xHA, HIS+, 
PAP1-13xMyc, TRP+ 
 
Medler et al, 2011 
YMH14 MATα cyc1-5000 cyc7-67 ura3-52 leu2-
3,112 cyh2 
 
Pinto, 1994 
YMH124 MATα cyc1-5000 cyc7-67 ura3-52 leu2-
3,112 cyh2 sua7-1 
 
Pinto, 1994 
SAM64 MATα cyc1-5000 cyc7-67 ura3-52 leu2-
3,112 cyh2 sua7-1, SUA7-3xHA, 
Medler et al, 2011 
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B.2. STRAINS USED IN CHAPTER III 
KANMX 
 
SFS1 MATα cyc1-5000 cyc7-67 ura3-52 leu2-
3,112 cyh2 sua7-1, SUA7-3xHA, 
KANMX, PCF11-13xMyc, TRP+ 
 
Medler et al, 2011 
SFS2 MATα cyc1-5000 cyc7-67 ura3-52 leu2-
3,112 cyh2 sua7-1, SUA7-3xHA, 
KANMX, PAP1-13xMyc, TRP+ 
 
Medler et al, 2011 
SFS3 MATα cyc1-5000 cyc7-67 ura3-52 leu2-
3,112 cyh2 sua7-1, SUA7-3xHA, 
KANMX, RNA15-13xMyc, TRP+ 
 
Medler et al, 2011 
SAM68 MATa his3Δ200 trp1Δ63 leu2Δ0 
met15Δ0 ura3Δ0, TBP-3xHA, HIS+ 
 
Medler et al, 2011 
YMH804 MATa ura3 leu2 trp1 his3 ade2 ade3 
can1 kin28Δ::trp1 (pKIN28-HA) 
 
Hampsey lab 
SHY407B MATα ade2Δ his3Δ200 leu2Δ0 met15Δ0 
trp1Δ ura3Δ0 RPB9-Flag1-TAP::TRP1 
 
Rani, 2004 
rna14-1 MATα ura3-1 trp1-1 ade2-1 leu2-3,112 
his3-11,15 rna14-1 
 
Minveill-Sebastia, 1994 
AA1 MATα ura3-1 trp1-1 ade2-1 leu2-3,112 
his3-11,15 rna14-1 SUA7-TAP, TRP+ 
 
Medler et al, 2011 
pcf11-2 MATa ura3-1 trp1Δ ade2-1 leu2-3,112 
his3-11,15 pcf11Δ::TRP1/pEL36-pcf11-2 
 
Amrani, 1997 
NAH12 MATa ura3-1 trp1Δ ade2-1 leu2-3,112 
his3-11,15 pcf11Δ::TRP1/pEL36-pcf11-2 
SUA7-TAP, TRP+ 
 
Medler et al, 2011 
hrp1-5 MATα cup1Δ ura3 his3 trp1 lys2 ade2 
leu2 hrp1::HIS3[pRS315-hrp1-L205S 
(LEU2)] 
 
Kessler, 1997 
NAH13 MATα cup1Δ ura3 his3 trp1 lys2 ade2 
leu2 hrp1::HIS3[pRS315-hrp1-L205S 
(LEU2)]  SUA7-TAP, TRP+ 
 
Medler et al, 2011 
pap1-1 MATa ade1/ade2 lys2 ura3-52 pap1-1 
 
Patel, 1992 
AA2 MATa ade1/ade2 lys2 ura3-52 pap1-1  
SUA7-TAP, TRP+ 
 
Medler et al, 2011 
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BY4733 MATa his3200 trp163 leu20 
met150 ura30 
Hampsey lab 
BPM5 MATa his3200 trp163 leu20 
met150 ura30, TFB4-TAP, URA+ 
This study 
SAM89 MATa his3200 trp163 leu20 
met150 ura30, KIN28-TAP, URA+ 
This study 
SAM90 MATa his3200 trp163 leu20 
met150 ura30, SSL2-TAP, URA+ 
This study 
SAM93 MATa his3200 trp163 leu20 
met150 ura30, KIN28-TAP, URA+, 
RNA15-13xMyc, TRP+ 
This study 
SAM51 MATa his3Δ200 trp1Δ63 leu2Δ0 
met15Δ0 ura3Δ0, RNA15-13xMyc, TRP+ 
El Kaderi et al, 2009 
SAM94 MATa his3200 trp163 leu20 
met150 ura30, KIN28-TAP, URA+, 
SSU72-13xMyc, TRP+ 
This study 
SAM103 MATa his3Δ200 trp1Δ63 leu2Δ0 
met15Δ0 ura3Δ0, SSU72-13xMyc, TRP+ 
This study 
yFR763 MATα, ade::higG, his3200, leu20, 
lys20,met150,trp163,ura30 
kin28::kin28-L83G [pSH579, ARS CEN 
URA3 kin28-L83G] 
Liu Y et al, 2004 
SAM99 MATα, ade::higG, his3200, leu20, 
lys20,met150,trp163,ura30 
kin28::kin28-L83G [pSH579, ARS CEN 
URA3 kin28-L83G] Kin28as-TAP, TRP+ 
This study 
SAM101 MATα, ade::higG, his3200, leu20, 
lys20,met150,trp163,ura30 
kin28::kin28-L83G [pSH579, ARS CEN 
URA3 kin28-L83G] Kin28as-TAP, TRP+, 
This study 
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RNA15-13xMyc, HIS+ 
SAM102 MATα, ade::higG, his3200, leu20, 
lys20,met150,trp163,ura30 
kin28::kin28-L83G [pSH579, ARS CEN 
URA3 kin28-L83G] Kin28as-TAP, TRP+, 
SSU72-13xMyc, HIS+ 
Pinto, 1994 
SAM104 MATα, ade::higG, his3200, leu20, 
lys20,met150,trp163,ura30 
kin28::kin28-L83G [pSH579, ARS CEN 
URA3 kin28-L83G] RNA15-13xMyc, 
HIS+ 
This study 
SAM105 MATα, ade::higG, his3200, leu20, 
lys20,met150,trp163,ura30 
kin28::kin28-L83G [pSH579, ARS CEN 
URA3 kin28-L83G] SSU72-13xMyc, 
HIS+ 
This study 
SAM106 MATα, ade::higG, his3200, leu20, 
lys20,met150,trp163,ura30 
kin28::kin28-L83G [pSH579, ARS CEN 
URA3 kin28-L83G] RPB4-13xMyc, HIS+ 
This study 
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APPENDIX C: PRIMERS 
C.1. RT Primers 
 
cDNA 
    Name 
 
                                     Sequence 
Oligo dT 
 
TTTTTTTTTTTTTTTTTTTTTTTTT 
18s 
 
GACGGAGTTTCACAAGATTACC 
CHA1 d1 
 
GGAAAAAATCAATACTAGCAAAATA 
CHA1 d2 
 
GCTTTTCTTCACTTAGTAAGGATTAA 
CHA1 d3 
 
CTGGGGTCTTCATTTGTGTCA 
ACT1 d1 
 
GATAAAGTCAGTGCTTAAACACGTC 
ACT1 d2 
 
ATAAAACTGAAAAGCGATGAAGAG 
ACT1 d3 
 
TTTGCGTAACGTTTGGATGG 
 
18s Control-PCR 
    Name 
 
                                     Sequence 
18s F 
 
GGAATAATAGAATAGGACGTTTGG 
18s R 
 
GTTAAGGTCTCGTTCGTTATCG 
 
Gene Specific RT-PCR Primers 
    Name 
 
                                     Sequence 
CHA1 F 
 
AATTCAAAAGGACGGTAAAAGAT 
CHA1 R 
 
AAGGGATGAACATAAATGGGC 
MET16 F 
 
CATTTGGTTTGACTGGCTTGG 
MET16 R 
 
TCGTACTTGTCATCATCTTTCTCC 
INO1 F 
 
GATATCCAGAATTTCAAAGAAGAAAAC 
INO1 R 
 
TATTCTGCGGTGAACCATTAATATAG 
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ACT1 F 
 
TACTCTTTCTCCACCACTGCTG 
ACT1 R 
 
GATTTCCTTTTGCATTCTTTCG 
MSN5 F 
 
 CAATGCCAATCCAAACAGTG 
MSN5 R 
 
 CGCACTATTACACAGCACATTTA 
CMP1 F 
 
 AACCGCAGAATAATGAATAAAGTG 
CMP1 R 
 
 GATATAAGGTTGGGTTCTTTGCT 
SPC1 F 
 
 GTGCTCTCGCTACTTTTCTGG 
SPC1 R 
 
 CATTGTGCTGTTCAGAGAACCA 
IMD4 F 
 
 ATTGGTATGGGTTCTGGGTC 
IMD4 R 
 
 GCCTTCAATCTCTTACCATCC 
ASC1 F 
 
 CTTACGCTTTGTCTGCTTCTTG 
ASC1 R 
 
 GATGGTCTTGTCACGGGAAC 
GAL10 F 
 
 GATCTTCCATACAAAGTTACGGG 
GAL10 R 
 
 CACAAATCTTGCGTCATAACG 
HXT1 F 
 
 ATTTGGTATGAAGCACCACGA 
HXT1 R 
 
 GGGCGACCTCAGATATTAGCA 
 
C.2. C-Terminal Tagging Primers 
  Name 
 
                                     Sequence 
Gal4-HA-
tag-F2 
 
ATAACTATCTATTCGATGATGAAGATACCCCACCAAACCCAAAAAAAGA
G CGGATCCCCGGGTTAATTAA 
Gal4-HA-
tag-R1 
 
ATGCACAGTTGAAGTGAACTTGCGGGGTTTTTCAGTATCTACGATTCAT
T GAATTCGAGCTCGTTTAAAC 
5’Gal4-
HA-tag-D  
 
TGTGCGCCGTTTCTGTTATC 
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Ino2-HA-
tag-F2 
 
AGTCCATTAGAAGCGCAAATGAAGCACTACAGCACATACTGGATGATT
CC CGGATCCCCGGGTTAATTAA 
Ino2-HA-
tag-R1 
 
AAAATACATCCAACGGGAGGCCATTTTCATCACTAATAGCTTGTATGAG
C GAATTCGAGCTCGTTTAAAC 
5’Ino2-
HA-tag-D  
 
TTGTCTCCTTCCAGTTCGGG 
Met28-
HA-tag-
F2 
TTAAGTCTTTGAAATTGTTGAATGACATTAAGAGACGGAACATGGGCAG
G CGGATCCCCGGGTTAATTAA 
Met28-
HA-tag-
R1 
ATCGAAGTTGGAGAGGAAAAACAAGACATCAGGCCCGCACGTTTCGC
GGG GAATTCGAGCTCGTTTAAAC 
5’Met28-
HA-tag-D  
 
GGTGGGAAAAGAAATCAACAAAC  
F2-Myc-
RNA14  
 
TTTTAAATGATCAAGTAGAGATTCCAACAGTTGAGAGCA  
CCAAGTCAGGTCGGATCCCCGGGTTAATTAA  
R1- Myc-
RNA14  
 
AGATGTGTTGGTATAAATATTCATATATACCTATTTATTA  
ACGTAATGTTAGAATTCGAGCTCGTTTAAAC  
F2- Myc-
RNA15  
 
CTATTTGGGACTTAAAACAAAAAGCATTAAGGGGAGAA  
TTTGGTGCATTTCGGATCCCCGGGTTAATTAA  
R1- Myc-
RNA15  
 
ATCATTGCGGAACCGCATTTTTTTTTTGTATTTTTGCCTCC  
CTAGTTTCAGAATTCGAGCTCGTTTAAAC  
F2- Myc-
PCF11  
 
CTAATAGTGGCAAGGTCGGTTTGGATGACTTAAAGAAAT  
TGGTCACAAAACGGATCCCCGGGTTAATTAA  
R1- Myc-
PCF11  
 
TAATATAATATATAGTTATTAAATTTAAATGTATATATGC  
AGTTCTGCTCGAATTCGAGCTCGTTTAAAC  
F2- Myc-
HRP1  
 
GTCGCGGTGGATACAATAGACGTAATAATGGCTACCATC  
CATATAATAGGCGGATCCCCGGGTTAATTAA  
R1- Myc-
HRP1  
 
TGAATTATACAAGAAAACTTTTCTCTAGTTTTCTACACTT  
TTCTTTTTTTGAATTCGAGCTCGTTTAAAC  
F2- Myc-
CLP1  
 
GCCGACTTCCCAGCAAGGCGATGATTCTAACTTCATATA  
GATATTTAGAGCGGATCCCCGGGTTAATTAA  
R2- Myc- TACGATATTTGTATGGATTTGATATAAGGCTCTTGAACA  
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CLP1  
 
GATAATTTTACGAATTCGAGCTCGTTTAAAC  
F2- Myc-
PAP1  
 
CTGCTTCAGGTGACAACATCAATGGCACAACCGCAGCTG  
TTGACGTAAACCGGATCCCCGGGTTAATTAA  
R1- Myc-
PAP1  
 
TGACTGATTAACCTATATTAATAAACTATTCAACTATAA  
ATAGGAATGTCGAATTCGAGCTCGTTTAAAC  
F2-HA-
TFIIB  
 
TTGCTAATGGTGTAGTGTCTTTGGATAACTTACCGGGCG  
TTGAAAAGAAACGGATCCCCGGGTTAATTAA  
R1-HA-
TFIIB  
 
CACGAGTACCCGTGCTTCTTGTTCCTATAATTTACTGTTT  
TATCACTTCAGAATTCGAGCTCGTTTAAAC  
RNA15-
Myc-Diag  
 
TCCAGGCCGCAAGAAGAG  
 
RNA14-
Myc-Diag  
 
AAGAGACTCAGAGCTTCCAACAG  
 
PCF11-
Myc-Diag  
 
GTCCAATTTGTAAGGAAACCG  
 
HRP1-
Myc-Diag  
 
AGCAAGATTCAAATGCCACTC  
 
PAP1-
Myc-Diag  
 
GTAACAGATGAAAATAAAGAGGAAGAA  
 
CLP1-
Myc-Diag  
 
TTGAGTCCTTATGCTATTGGTGTT  
 
TFIIB-
HA-Diag  
 
CCGATGCAAGTCACTACTTCTG  
 
Myc-tag- 
Diag 
CAAGTCTTCCTCGGAGATTAGC  
 
HA-tag-
Diag  
 
GGTAGAGGTGTGGTCAATAAGAGC  
 
5’ KIN28- 
Myc/HA-
F2 
TCAAAGAATTACCACCACCAAGTGACCCGTCTTCAATAAAAATACGTAA
CCGGATCCCCGGGTTAATTAA 
 
3’ KIN28- 
Myc/HA-
F2 
GATACATCTAATGTCAATAACACAGATTCTACAAATTTTATAAAATCATA
GAATTCGAGCTCGTTTAAAC 
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5’ KIN28-
Tag-Diag 
CGCCTTAGATTTTATGTGTGGA 
 
5’ 
SSU72-
Myc-F2 
GGCAAAGCTCACATTCTCAACTACCGTCATTATACGCTCCTTCATATTA
CCGGATCCCCGGGTTAATTAA 
 
3’ 
SSU72-
Myc-R1 
ATGAGGGCCGCTTAATGCTTATGCTTTTCTACAGTAATTGACCGTTTTG
TGAATTCGAGCTCGTTTAAAC 
 
5’ SSU72 
–Tag 
diag 
ATGATGATGAAAATGCTAAAATTG 
 
5’ TFB4-
C-TAP 
 
GGAAACCAGTTGTTCCAAGGTTGAAAGCCAAAAAGAAGGTGACGAAAC
CATCCATGGAAAAGAGAAG 
 
3’ TFB4-
C-TAP 
 
ATTGTGACGAAGGTTACCTGCTTGAAACGGATAATGTTCATTCCTTTCG
TTACGACTCACTATAGGG 
 
TFB4-
TAP-
DIAG 
AGGACATCATGCTATTTAACAGGG 
 
5’ C-TAP 
Ssl2 
 
AGGAACATCATCCATTAATCAGAAAGATGTATTATAAGAATTTGAAGAA
GTCCATGGAAAAGAGAAG 
 
3’C-TAP 
Ssl2 
 
TATGACTGAATAGATTCAAAATAGGAAGGTGACAATGAAACCAAGCCTA
TTACGACTCACTATAGGG 
 
5’C-TAP 
SSL2-
Diag 
TTACACATTTACACGGAATGGAG 
 
5’C-TAP 
kin28 
 
TCAAAGAATTACCACCACCAAGTGACCCGTCTTCAATAAAAATACGTAA
CTCCATGGAAAAGAGAAG 
3’C-TAP 
kin28 
GATACATCTAATGTCAATAACACAGATTCTACAAATTTTATAAAATCATA 
TACGACTCACTATAGGG 
5’C-TAP 
kin28-
Diag 
CGAAGTTTCTTCCTTTATGACG 
 
5’RNA15-
TAP-C 
 
CTATTTGGGACTTAAAACAAAAAGCATTAAGGGGAGAATTTGGTGCATT
TTCCATGGAAAAGAGAAG 
 
3’RNA15 
–TAP-C 
 
ATCATTGCGGAACCGCATTTTTTTTTTGTATTTTTGCCTCCCTAGTTTCA 
TACGACTCACTATAGGG 
 
5’TAP-
Rna15-D 
TCCAGGCCGCAAGAAGAG 
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C.3. ChIP Primers 
 
INO1-ChIP 
    Name 
 
                                        Sequence                      
CHA1 A 
 
GATAGCCTCTTGCGACCTTATT 
 
 
CATTCATATTTCAAGAAAAATTGTG 
CHA1 B 
 
AATTCAAAAGGACGGTAAAAGAT 
 
 
AAGGGATGAACATAAATGGGC 
CHA1 C 
 
GGTGGAAACGAATGGATGTC 
 
 
TCTTAGTGTTGTAACCCAAATGC 
CHA1 D 
 
GGAAGAAGCGTTGGATAGCAT 
 
 
CCCCTTTATACAAATTCTGTGC 
 
MET16 ChIP 
    Name 
 
                                        Sequence                      
INO1 A 
 
GCTTGTTCTGTTGTCGGGTTC 
 
 
GGAGGTGATTGGAGCAATATTATC 
INO1 B 
 
GATATCCAGAATTTCAAAGAAGAAAAC 
 
 
TATTCTGCGGTGAACCATTAATATAG 
INO1 C GTATTAAACCGGTCTCCATTGC 
5’Ssu72-
C-TAP 
 
GGCAAAGCTCACATTCTCAACTACCGTCATTATACGCTCCTTCATATTA
CTCCATGGAAAAGAGAAG 
 
3’Ssu72-
C-TAP 
 
ATGAGGGCCGCTTAATGCTTATGCTTTTCTACAGTAATTGACCGTTTTG
TTACGACTCACTATAGGG 
 
5’Ssu72-
C-TAP-
Diag 
GTGAAGATTTGATGAATAGAGG 
 
3’ ANY 
TAP Diag 
GTTGAATTTGTTGTCTACTTTCGG  
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CCGACGGGCTTCATATATTTG 
INO1 D 
 
CTCATTTCAACGACTCTCTTTTTC 
 
 
GCACTTTCTCGCATCTACCTCA 
 
HXT1 ChIP 
    Name 
 
                                        Sequence                      
HXT1 P 
 
GCGATGAGATAAGATAAAAGGGA 
 
 
GATTACCGATTCCTCTACTTTTGA 
HXT1 M 
 
ATTTGGTATGAAGCACCACGA 
 
 
GGGCGACCTCAGATATTAGCA 
HXT1 T 
 
GGTGGAAACGAATGGATGTC 
 
 
TCTTAGTGTTGTAACCCAAATGC 
 
CHA1 ChIP 
    Name 
 
                                        Sequence                      
CHA1 P 
 
GCCCCAGCGGAAATGTAA 
 
 
CATTCATATTTCAAGAAAAATTGTG 
CHA1 M 
 
GCCCAGGTTATCGTGAGTG 
 
 
CACCTCCACCAACGCTGC 
CHA1 T 
 
GGAAGAAGCGTTGGATAGCAT 
 CAGTAGTTTATGCTTTATGCTCG 
 
CHA1 D1 
 
GCACAGAATTTGTATAAAGGGG 
 
 
GCTTTTCTTCACTTAGTAAGGATTAA 
CHA1 D2 
 
GTTCCGTAATAATCTTCCCAGC 
 CTGGGGTCTTCATTTGTGTCA 
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ASC1 ChIP 
    Name 
 
                                       Sequence 
ASC1 P 
 
GACTGCTCCTTTGGTTTTCC 
 
 
GGTTGACCAGCAGAAGTAGCC 
ASC1 M 
 
CGAAAAAGCTGATGATGACTCTG 
 
 
TTGATGTTGGAGTTGTGACCG 
ASC1 T 
 
TGGCAAGTTATGACTGCTAACTAAG 
 
 
GCCAAGGAGACTGAATTTAATG 
 
ACT1 ChIP 
    Name 
 
                                       Sequence 
ACT1 P 
 
CAAACTCGCCTCTCTCTCTCC 
 
 
GCAAGCGCTAGAACATACCAG 
ACT1 M 
 
CATACCTTCTACAACGAATTGAGAG 
 
 
CTTCATCAAGTAGTCAGTCAAATCTC 
ACT1 T 
 
TGGTCCATCTATCGTTCACCA 
 
 
ATAAAACTGAAAAGCGATGAAGAG 
ACT1 D1 
 
GTTTTGTCTCTCCCTTTTCTACG 
 
 
GGTATCAAAACGCCGGACTC 
ACT1 D2 
 
CCGCCATTAGAATTTGAGTCC 
 
 
TTTGCGTAACGTTTGGATGG 
 
C.4. CCC Primers 
 
HXT1 CCC            
    Name                                             Sequence 
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HXT1 P1 
 
TCGGGTGTTAAGAAATATTTTGC 
HXT1 T1 
 
TTAACAGATAACCGAGTCGATCTC 
HXT1 C1 
 
AATACCACATAGGCGCTATACATAG 
HXT1 C2 
 
CGTCTTTTCTTTACTGCTTCACC 
 
CHA1 CCC            
    Name 
 
                                            Sequence 
CHA1 P1 
 
GGAAAATGTTTATACAGTTTTCTCTT 
CHA1 T1 
 
GGAAAATGTTTATACAGTTTTCTCTT 
CHA1 C1 
 
GGAAGAAGCGTTGGATAGCAT 
CHA1 C2 
 
CGTTTTGGATATGTTGATGCTTAC 
 
ACT1 CCC            
    Name 
 
                                            Sequence 
ACT1 P1 
 
CGAGTTTGGTTTCAAAACGG 
ACT1 T1 
 
CCGCCATTAGAATTTGAGTCC 
ACT1 C1 
 
TGGTCCATCTATCGTTCACCA 
ACT1 C2 
 
AATTTTCGTAGAAAAGGGAGAGAC 
 
ASC1 CCC            
    Name 
 
                                            Sequence 
ASC1 P1 
 
GACTGCTCCTTTGGTTTTCC 
ASC1 T1 
 
CTTTATTTCCTTTATTGTGGTATTAG 
ASC1 C1 
 
ATGCTGTTTCTTTGGCTTGG 
ASC1 C2 
 
TGTACATATGTATTTTCGCAGCA 
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APPENDIX D: MEDIA 
YEAST EXTRACT-PEPTON-DEXTROSE (YPD) medium (1 liter) 
 
INOSITOL DROP-OUT MEDIUM (1 liter) 
Component Quantity                             Notes 
 
Ammonium Sulfate 
 
5 g  
Vitamin Stock  1 ml 
 
Of 1000X stock solution 
Trace Elements Stock 1 ml 
 
Of 1000X stock solution 
Salt Mix 1.7 g 
 
 
Inositol drop-out amino 
acid Mix 
230 mg 
 
 
Dextrose 20 g   100 ml of 20% stock-add after autoclaving 
 
TRACE ELEMNTS STOCK (1000X; 100 ml)-FOR INOSITOL DROP-OUT MEDIA 
 
Component Quantity                             Notes 
Yeast extract 10 g  
Peptone 20 g  
Dextrose 20 g   100 ml of 20% stock-add after autoclaving 
Agar 20 g   For plates only 
NaOH  1 pellet   For plates only 
Component Quantity                         Notes 
 
Boric acid 
 
50 mg Autoclave 
 
Store in a dark bottle at 4oC 
 
 
 
Copper sulfate 4 mg 
 
Potassium iodide                          10 mg 
 
Ferric chloride 20 mg 
 
Manganese sulfate                      40 mg 
 
Sodium molybdate       
        
20 mg 
 
Zinc sulfate                       40 mg 
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VITAMIN STOCK (1000X; 100 ml)- FOR INOSITOL DROP-OUT MEDIA 
 
 SALT MIX- FOR INOSITOL DROP-OUT MEDIA 
 
 AMINO ACID MIX- FOR INOSITOL DROP-OUT MEDIA 
Component Quantity  Notes 
 
Biotin  2 mg 
 
 
Autoclave 
 
Store in a dark bottle at 4oC 
 
Calcium pantothenate                200 mg 
 
Folic acid                                           0.2 mg 
 
Niacin              40 mg 
 
β-Aminobenzoic acid                    20 mg 
 
Pyridoxine hydrochloride              40 mg 
 
Riboflavin                                           20 mg 
 
Thiamin hydrochloride                  40 mg 
 
Component Quantity                          Notes 
 
Potassium phosphate monobasic    85 g  
 
Potassium phosphate dibasic          15 g  
 
Magnesium sulfate                           50 g  
 
Sodium chloride                               10 g  
 
Calcium chloride                              10 g  
 
Component Quantity  Notes 
 
Adenine hemisulfate                     40 mg 
 
 
 
Histidine 20 mg  
 
Leucine   60 mg  
 
Lysine 30 mg  
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 INOSITOL STOCK (100 X; 100 ml) 
Component Quantity                       Notes 
 
Inositol ( for plus inositol medium) 1 g   1 ml/ liter of inositol drop-out 
  medium 
 
 
 METHIONINE DROP-OUT MEDIUM (1 liter) 
Component Quantity 
 
                      Notes 
Yeast nitrogenous base  6.7 g   without amino acids 
 
methionine drop-out mix 1 g  
 
agar 20 g   For plates only 
 
NaOH 
 
1 pellet   For plates only 
Dextrose  20 g 
 
  100 ml of 20% stock-add after 
  autoclaving 
 
  METHIONINE DROP-OUT MIX- FOR METHIONINE DROP-OUT MEDIA 
Component Quantity                        Notes 
 
Adenine 2.5 g 
 
 
L-arginine 1.2 g 
 
 
L- asparatic acid 6.0 g 
 
 
L- glutamic acid 6.0 g 
 
 
L-Histidine 1.2 g 
 
 
L-leucine  3.6 g 
 
 
L-lysine 1.8 g 
 
 
L-phenylalanine 3.0 g  
Methionine     20 mg  
 
Tryptophan   40 mg  
 
Uracil     20 mg  
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L-tryptophan 2.4 g 
 
 
L-tyrosine 1.8 g 
 
 
L-valine 9.0 g 
 
 
Uracil 1.2 g 
 
 
 
AMMONIUM SULFATE MEDIUM (1 liter)-FOR CHA1 REPRESSION 
Component Quantity                               Notes 
 
 Yeast nitrogenous base  1.7 g 
 
  Without amino acids 
  Without ammonium sulfate 
Ammonium sulfate 5 g  
 
Amino acid mix 230 mg  
 
Dextrose  20 g 
 
  100 ml of 20% stock-add after 
  autoclaving 
 
SERINE-THREONINE MEDIUM (1 liter)-FOR CHA1 ACTIVATION 
Component Quantity                               Notes 
 
 Yeast nitrogenous base  1.7 g 
 
  Without amino acids 
  Without ammonium sulfate 
L-serine 1 g  
 
L-threonine 1 g  
Amino acid mix 230 mg  
 
Dextrose  20 g 
 
  100 ml of 20% stock-add after 
  autoclaving 
 
 AMINO ACID MIX FOR CHA1 MEDIA 
Component Quantity                           Notes 
 
Adenine hemisulfate                     40 mg 
 
 
 
Histidine 20 mg  
 
Leucine   60 mg  
 
Lysine 30 mg  
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TRYPTON DROP-OUT MEDIUM (1 liter) 
Component Quantity 
 
                      Notes 
Yeast nitrogenous base  6.7 g   without amino acids 
 
Trypton drop-out amino acid mix  1 g  
 
agar 20 g  
 
NaOH 
 
1 pellet  
Dextrose  20 g 
 
  100 ml of 20% stock-add after 
  autoclaving 
 
TRYPTON DROP-OUT MIX 
 
Methionine     20 mg  
 
Tryptophan   40 mg  
 
Uracil     20 mg  
 
Component Quatity                       Notes 
 
Adenine 2.5 g  
 
L-arginine 1.2 g  
 
L- asparatic acid 6.0 g  
 
L- glutamic acid 6.0 g  
 
L-Histidine 1.2 g  
 
L-leucine  3.6 g   
 
L-lysine 1.8 g  
 
L-methionine 1.2 g  
 
L-phenylalanine 3.0 g  
 
L-tyrosine 1.8 g  
 
L-valine 9.0 g  
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G418 PLATES (KMX-MEDIUM) -1 liter 
 
2XYT MEDIUM-1 liter 
 
  
 
Uracil 1.2 g  
 
Component Quantity 
 
Notes 
Yeast nitrogenous base  10.0 g   without amino acids 
 
peptone 20.0 g  
 
agar 20.0 g  
 
Dextrose  20 g 
 
  100 ml of 20% stock-add after 
  autoclaving 
G418 
 
1.0 ml   Of 400 mg/ml  
Component Quantity 
 
Notes 
Yeast extract  10.0 g   without amino acids 
 
Tryptone 16.0 g  
 
NaCl 5.0 g  
 
Agar 
 
20.0 g   For plates only 
132 
 
 
 
APPENDIX E: BUFFERS AND SOLUTIONS 
 
STOCK SOLUTIONS 
Reagent   Molarity/ concentration/   
         percentage 
                    Notes 
 
Tris-HCl- pH 8.0  1.0 M 
 
 Adjust  pH  using HCl 
EDTA  pH 7.0 to 8.0 0.5 M  Adjust pH using  NaOH 
 
NaCl 5.0 M  Autoclave 
 
KCl 2.0M  Autoclave 
 
SDS 10% 
 
 Filter sterilize 
CaCl2 1.0 M  Autoclave 
 
MgCl2 1.0  M  Autoclave 
 
 PEG  (Mw 4000) 
 
50 %  Filter sterilize 
LiOAc 
 
1.0 M  Filter sterilize 
Glycine 2.5 M  Autoclave 
 
Ammounium acetate  
 
7.5 M  Autoclave 
NaOAc pH 5.2 3.0 M  Adjust pH using glacial 
acetic acid 
Glycerol 50 %  Autoclave 
 
Tergitol 10 %  Autoclave 
 
Triton X-100 10 %  Filter sterilize 
 
LiCl 5.0 M 
 
 Autoclave 
 
HEPES pH 7.9 1.0 M  Adjust the pH using 
KOH 
 Filter sterilize 
Sodium deoxycholate 10%  Filter sterilize 
 
KOH 10.0 M 
 
 
 Autoclave 
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AGAROSE GEL ELECTROPHORESIS BUFFER (1X TAE) 
Component Concentration                   Notes 
 
Tris-acetate 40 mM  Autoclave 
 
0.5 M EDTA pH 8.0 1 mM EDTA  Autoclave 
 
 
SOLUTIONS FOR YEAST GENOMIC DNA EXTRACTION 
  
SOLUTIONS FOR LiOAc/DMSO YEAST TRANSFORMATION 
Dextrose 20 %  Autoclave 
 
PMSF 100 mM 
 
 Don’t autoclave 
 Keep at 4oC 
Glycogen 20 mg/ ml  Filter sterilize 
 
DTT 1.0 M  Filter sterilize 
 
Ethedium  bromide 10.0 mg / ml  Don’t autoclave 
 Keep at 4oC 
Ammonium acetate 7.5 M  Autoclave  
 
TE 10X 
 
 100 mM Tris.HCl pH 8.0 
 10 mM EDTA 
TAE 
 
50 X  2.0 M Tris-acetate 
 50 mM EDTA 
TBS 
 
10X  100 mM Tris-HCl pH 8 
 2M NaCl 
Reagent Composition                  Notes 
 
Lysis buffer 2% Triton X-100 
100 mM NaCl 
10 mM Tris-HCl pH 8.0 
10 mM EDTA 
1% SDS 
 
Reagent Composition                  Notes 
LiAOAc buffer 0.1 M LiAOAc 
10 mM Tris-HCl(pH=8.0) 
1 mM EDTA 
 
PEG solution 50 % w/v PEG (M.W. = 
4000) 
Filter sterilize  
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SOLUTIONS FOR PLASMID MINIPREP 
 
YEAST CELL WASH  
 
CHROMATIN IMMUNOPRECIPITATION (ChIP) BUFFERS AND SOLUTIONS 
FA-LYSIS BUFFER 
0.1 LiAOAc  
10 mM Tris-HCl (pH=8.0) 
1 mM EDTA 
DMSO 100 %  
Solution Composition               Notes 
Solution I 50 mM Dex 
10 mM EDTA 
25 mM Tris-HCl pH 8.0  
 
Solution II 
  
0.1 N NaOH 
1% SDS 
 
Solution III  
 
 
30 ml 5M KOAc  
5.75 ml glacial HOAc 
14.25 ml H2O 
 Store at – 20 oC 
component Concentration                Notes 
Wash buffer I 1X  TBS  Autoclave 
Wash buffer II  1XTBS 
1%  Triton X-100 
 Autoclave 
Reagent Concentration                Notes 
 
HEPES-KOH pH 7.9 50 mM 
 
 
 Store at -20 °C 
 
 
 
 
 
NaCl 
 
140 mM 
EDTA 
 
1 mM 
Triton X-100 
 
1 % 
Sodium Deoxycholate 
 
0.1 % 
 
PMSF 
 
1 mM 
SDS 0.07 % 
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FA-LYSIS BUFFER + 500 mM NaCl  
Reagent Stock 
Concentration 
Volume added 
HEPES-KOH pH 7.9- 8.0 
 
 
50 mM  
 Store at –20 °C  
 
 
 
 
 
 
 
NaCl 
 
500 mM 
EDTA pH 8.0  
 
1 mM 
Triton X-100 
 
1 % 
Sodium Deoxycholate 
 
0.1 % 
PMSF 
 
1 mM 
SDS 
 
0.07 % 
 
ChIP WASH BUFFER  
             Reagent 
 
Concentration Notes 
Tris-HCl pH 7.5 to 8 
 
10 mM  Store at -20 °C 
LiCl 
 
250 mM 
Triton X-100 
 
0.5 % 
EDTA pH 8.0 
 
1 mM 
Sodium Deoxycholate 
 
0.5 % 
SDS 
 
0.1 % 
 
ChIP ELUTION BUFFER  
Reagent Concentration Notes 
 
 
Tris-HCl pH 7.5 to 8.0  
 
50 mM  Store at room temperature 
SDS 1 % 
 
EDTA pH 8.0 10 mM 
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REVRESE TRANSCRIPTION PCR (RT-PCR) BUFFERS AND SOLUTIONS 
HIGH TE BUFFER 
Reagent Concentration Notes 
Tris-HCl pH 7.5 50 mM  Store at RT 
 
EDTA  20 mM  
 
 
RNA-LYSIS BUFFER 
 
CHROMOSOME CONFORMATION CAPTURE SOLUTION 
TM BUFFER 
 
TRANSCRIPTION RUN-ON ASSAY SOLUTIONS AND BUFFERS 
Reagent Concentration Notes 
 
Tris-HCl pH 8.0 
 
80 mM  
CaCl2  
 
10 mM  
β-mercatoethanol 
 
10 mM  
VCR (Shake well) 
 
10 mM  
Component Concentration Notes 
 
Tris HCl pH 7.5- 8.0 
 
10 mM  
MgCl 2 
 
5 mM  
Reagent Composition Notes 
 
20X SSC 
3 M NaCL 
300mM Na3CitrateX2H2O 
 Adjust pH to 7.0 
using HCl 
Sarkosyl 10% 
 
 
Boiling solution 
 
0.4 N NaOH 
1 mM EDTA 
 
Hybridization 
solution 
0.5M potassium phosphate pH 7.2 
7%  SDS 
 
 
Membrane wash I 
 
0.1% SDS 
1% SSC 
 
 
Membrane wash II 
0.1% SDS 
0.1% SSC 
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IMMUNOPRECIPITATION ASSAY BUFFERS AND SOLUTIONS 
2.5 XRun-on buffer 
50 mM Tris-HCl pH 7.5 
500 mM KCl 
80 mM MgCl2 
5 mM DTT 
 
NTPs/RNase 
inhibitor mix 
 
10 mM each of CTP, ATP, and GTP 
300 units of RNase Inhibitor 
7 μl of [α-32P]-UTP (3000 Ci/mmol, 
10 μCi/μl 
 
TMN buffer 
10 mM Tris-HCl pH 7.5 
5 mM MgCl2 
100 mM NaCl 
 
NaOAc/HOAc mix 
 
0.3 M sodium acetate pH 5.2 
0.5 μl of glacial acetic acid 
 
 
LETS buffer 
 
0.1 M LiCl 
0.2% SDS 
10 mM EDTA 
10 mM Tris-HCl pH 7.5 
 
Component Concentration Notes 
IP lysis buffer 10% glycerol 
20 mM Tris-HCl pH 8.0 
50 mM KCl 
0.5 mM EDTA 
1 mM MgCl2 
0.1% TritonX-100 
1 mM PMSF (add directly before 
use) 
 Autoclave 
 Keep at 4oC 
30%Acrylamide:Bis Solution 1 %  Bisacrylamide 
29%  Acrylamide 
 
 
4% stacking gel 
 
125 mM Tris-Cl, pH 6.8 
0.1% SDS 
5% Acrylamid  mix 
0.1 Ammonium persulfate 
 
 Keep at 4oC 
Electrode buffer 
 
25 mM tris 
250 mM glycine 
0.1 SDS 
 
5X laemeli buffer 250 mM Tris HCl pH 6.8 
50 % Glycerol 
10% SDS 
2.8 M β-mercaptoethanol 
0.1% Bromophenol blue 
 
Transfer Buffer  20% Methanol  
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24 mM Tris-base 
192 mM Glycine 
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Gene looping, defined as the interaction of the promoter and the terminator 
regions of a gene during transcription, is emerging as an important gene regulatory 
mechanism in eukaryotes. The role of promoter bound general transcription factors 
during initiation is well established. However, recent studies have revealed that some 
initiation factors also interact with the 3’ end of a gene. The biological role of initiation 
factors at the 3’ end of a gene is unknown. The general transcription factors TFIIB and 
TFIIH have been found to interact genetically with Ssu72, a component of CPF 3’ end 
processing complex. Accordingly, we found that TFIIB and TFIIH localize to the distal 
ends of genes in a transcription dependent manner. TFIIB localization at the terminator 
region during transcription requires a functional CF1 complex. TFIIB physically interacts 
with the all subunits of the CF1 complex in an activator dependent manner. TFIIH also 
interacts with the CF1 and CPF 3’ end processing complexes in a manner depending on 
its kinase activity. Employing  affinity  chromatography  and  glycerol gradient 
centrifugation, we show that TFIIB associates with poly(A) polymerase and  the   CF1  
complex  in  yeast  cells to form a holo-TFIIB complex. This complex was resistant to 
184 
 
 
 
MNase digestion and brief exposure to high salt. The sedimentation coefficient of the 
holo-TFIIB complex was intermediate between that of TFIIH and TFIID.  Initiation factors 
which remain bound on a promoter scaffold in vitro, were not found in a holo-TFIIB 
complex with termination factors. The holo-TFIIB complex was observed only in the 
looping competent strains, but not in the looping defective sua7-1 strain. We further 
show that in sua7-1 cells, where a holo-TFIIB complex is not formed, the kinetics of 
activated transcription is altered. These results strongly suggest a role for TFIIB in 
termination of transcription. Similarly, the kinase dependent presence of TFIIH at the 3’ 
end of genes suggested a role for the factor in termination. Accordingly, we show that 
RNAP II read through the termination signal in the absence of Kin28 kinase activity. 
Furthermore, the recruitment of CF1 and CPF subunits at the 3’ end of a gene is 
impaired in the TFIIH kinase defective mutant. We propose that initiation factors are in 
contact with the terminator during gene looping and play an active role in transcription 
termination. 
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